Библиографический указатель

1. 
   Абражанов А.А. Оперативное лечение самородной (идиопатической) эпилепсии //Хирургия. - 1909, - №7. -С. 49-67.
   
2. 
   Алиханов А.А. Режим быстрых очищенных градиентов как средство магнитно-резонансной идентификации эпилептического очага //I Всеросс. конф. по детской нейрохирургии: Тез. докл. -М., 2003. -С. 184-185.
   
3. 
   Арушанян Э.Б. О двойственной роли хвостатого ядра в регуляции судорог //Журн. невропатол. и психиатр. -1975. - Т. 75, вып. 3. - С. 444-451.
   
4. 
   Асадуллаев М.М., Сысуев О.М. Профилактика нарушения функции слухового анализатора при воспалительных заболеваниях головного мозга с судорожным синдромом //Матер. I Междунар. конф. по проблеме формирования здорового образа жизни. -Астана, 1998. -С. 211-213.
   
5. 
   Асадуллаев М.М., Сысуев О.М., Муратов Ф.Х. Изменение регионарного мозгового кровотока при церебральных лептоменингитах с судорожным синдромом и применение препарата «Кавинтон» в комплексном их лечении //Значение кавинтона в лечении психических и неврологических расстройств при нарушении мозгового кровообращения: Матер. научн. конкурса. - М., 1998. -№ 32. -С. 14.
   
6. 
   Асадуллаев М.М., Сысуев О.М., Муратов Ф.Х. Применение препарата «Кавинтон» для коррекции функции слухового анализатора при церебральных лептоменингитах с судорожным синдромом //Значение кавинтона в лечении психических и неврологических расстройств при нарушении мозгового кровообращения: Матер. научн. конкурса. – М., 1998. - № 34. -С. 15.
   
7. 
   Асадуллаев М.М., Сысуев О.М., Рахимбаева Г.С. Клинико-нейрофизиологические и биохимические показатели в патогенезе развития судорог, обусловленных церебральным лептоменингитом //Неврология. -1999. -№ 2. -С. 16-18.
   
8. 
   Асадуллаев М.М., Сысуев О.М., Рахимбаева Г.С. Некоторые клинико-биохимические особенности развития судорожного синдрома у больных церебральным лептоменингитом //Истъедод. -1998. -№8. -С. 31-34.
   
9. 
   Асадуллаев М.М., Сысуев О.М., Рахимбаева Г.С. Новые особенности фармакологического действия противосудорожного препарата «депакина» //Бюлл. ассоц. врачей Узбекистана. -1999. -№ 2. -С. 65-67.
   
10. 
    Астапенко А.В., И.П. Антонов, В.Б. Шалькевич, Г.И. Овсянкина //Применение танакана в неврологической практике// Мед. новости (Минск). –1999. –№ 1–2. –С.32–33.
    
11. 
    Ашмарина И.П., Стуколова П.В. Нейрохимия. -М.: НИИ биомедхимии, 1996. - 418 с.
    
12. 
    Бадалян Л.О., Темин П.А., Никанорова М.Ю. Медикаментозное лечение эпилепсии //Клин. мед. - 1990. - №11. -С. 10-15.
    
13. 
    Бейн Б.Н. Динамика ЭЭГ у больных эпилепсией после каллозотомии //Матер. III съезда нейрохирургов России. -СПб, 2002. -С. 458-459.
    
14. 
    Бейн Б.Н. О компенсации двигательных функций у больных с детской резидуальной энцефалопатией и эпилепсией после гемисферэктомии //Вопр. нейрохир. - 1984. - № 5. -С. 50-56.
    
15. 
    Бейн Б.Н., Рясик И. О. Каллозотомия в лечении резистентных форм эпилепсии //Ж. неврол. и психиатр. -2001. -Вып. 101,№6. -С. 56-62.
    
16. 
    Беляев В.П., Ревнивых Ю.А. Особенности клиники височной эпилепсии различной этиологии //Матер. Всесоюзн. конф. невропатологов, психиатров и нейрохирургов «Височная эпилепсия». -Тюмень,1970. -С. 38-43.
    
17. 
    Беляев Ю.И., Шевченко Л.Ю. Диагностика церебральной гемиатрофии и гемисферэктомия //Вопр. нейрохир. -1972. -№6. -С. 43-48.
    
18. 
    Берснев В.П., Хачатрян В.А., Земская А.Г., Яцук С.Л. Расширенная лобэктомия и гемисферэктомия в лечении фармакорезистентных форм эпилепсии у детей и подростков //Тез. докл. Всеросс. конф. по детской нейрохирургии. -М., 2003. -С. 171-172.
    
19. 
    Бехтерева Н.П., Можаев С.В., Аничков А.Д. Диагностика и хирургическое лечение височной эпилепсии //Матер. II съезда нейрохирургов России. -Н. Новгород, 1998. -С. 200.
    
20. 
    Болдырев А.И. Некоторые принципы оценки прогноза при эпилепсии //Журн. невропатолог. и психиатр. -1984. - №6. - С. 819-822.
    
21. 
    Болдырев А.И. Эпилепсия у взрослых - М.: Медицина, 1984. -185 с.
    
22. 
    Болдырев А.И. Эпилептические синдромы. - М.:Медицина,1976. -264 с.
    
23. 
    Болдырев А.И., Сигидиненко Л. В. Лечение больных с психомоторными приступами, резистентными к обычной противосудорожной терапии //Журн. невропатол. и психиатр. -1990. -Т. 90, вып. 6. -С. 60-61.
    
24. 
    Болондинский В.К., Пастухов В.А. Эффекты внутримозговых инъекций кинуренина на условнорефлекторную деятельность и содержание серотонина в крови собак //Журн. высш. нервн. деят. -1991. -Т. 41, вып. 6. -С. 1130-1134.
    
25. 
    Борейко В.Б. Дисфории в клинике височной эпилепсии и их динамика при хирургическом лечении //Матер. Всесоюзн. конф. невропатологов, психиатров и нейрохирургов «Височная эпилепсия». -Тюмень,1970. -С. 91-95.
    
26. 
    Бурцев В.М., Трошин В.Д., Трошин О.В. Основы неврологии: Рук-во в 3 т. - Н. Новгород: Изд-во НГУ, 1998. -560 с.
    
27. 
    Вейн А.М., Мосолов С.Н. Антиконвульсанты в психиатрической и неврологической практике. - СПб, 1994. - 336 с.
    
28. 
    Верещагин Н.В. Мозговое кровообращение. Современные методы исследования в клинической неврологии. - М.: Медицина, 1993. -345 с.
    
29. 
    Власов П.Н., Карлов В.А., Хабибова А.О. Депакин - 300 и депакин-хроно в терапии эпилепсии //Журн. невропатол. и психиатр. - 1999. -Т. 99, №10. - С. 10-14.
    
30. 
    Воронина Т.А. Антиконвульсанты в психиатрической и неврологической практике. - СПб, 1994. -С. 3-30.
    
31. 
    Воцьян Ю., Бача Т. Гемисферэктомия в лечении эпилепсии //Эпилептогенный очаг и хирургическое лечение эпилепсии. -Киев,1974. -№1. -С. 35.
    
32. 
    Вудли М., А.Уэлан Терапевтический справочник Вашингтонского университета: Пер. с англ.; Под ред..- М.: Практика, 1995.-832 с.
    
33. 
    Гариб Ф.Ю., Шамсиев А.М., Елисеева М.Р. Иммунозависимые болезни. - Ташкент, 1995. - 72 с.
    
34. 
    Гафуров Б.Г. Лечение эпилепсии. - Ташкент, 1995. -16 с.
    
35. 
    Гафуров Б.Г. Электроэнцефалография в практике невропатолога: Метод. реком. - Ташкент, 1992. - С. 8-12.
    
36. 
    Гафуров Б.Г. Эпилепсия: Метод. реком.. - Ташкент, 1995. -16 с.
    
37. 
    Герасимова М.М. Нервные болезни. - Тверь, 2000. - 507 с.
    
38. 
    Горкин В.З., Райгородская Д.И, Медведев А.Е, Федотова И.Б. //Изменение каталитических свойств митохондриальных моноаксидаз при аудиогенной эпилепсии в эксперименте// Вопр. мед. химии.-1991.-Т.37, № 2.-С.46-48.
    
39. 
    Громов С.А., Лобзин В.С. Лечение и реабилитация больных эпилепсией. - СПб., 1993. - 211 с.
    
40. 
    Громов С.А., Смирнов Д.П., Хоршев С.К. Совершенствование фармакотерапии эпилепсии с различной степенью резистентности к лекарственному лечению //Журн. невропатол. и психиатр. -1998. -Т. 3, №2. -С. 25-30.
    
41. 
    Гуревич В.С., Михайлова И.А. Влияние L-глутаминовой кислоты на АДФ - индуцированную агрегацию и активность Са, Mg-АТФазы тромбоцитов человека //Гематол. и трансфузиол. -1993. - №2.-С. 20-23.
    
42. 
    Гусев Е. И., Бурд Г.С. Эпилепсия. - М., 1994. -63 с.
    
43. 
    Гусев Е. И., Бурд Г.С., Коновалов А. Н. Неврология и нейрохирургия. М.: Медицина, 2000. - 656 с.
    
44. 
    Дамбинова С.А. Нейрорецепторы глутамата –Л. 1989-С. 19-28.
    
45. 
    Дзяк Л. А., Голик В.А., Рожкова И. В.. Опыт использования танакана в лечении церебральных ишемий, обусловленных патологией магистральных артерий головы в послеоперационном периоде //Танакан: Матер. научн.–практ. симп. –Киев, 1997. –С. 5–6.
    
46. 
    Дубенко А. Е. Энергетический обмен при эпилепсии //Журн. невропатол. и психиатр. -1998. -Т. 3, №5. -С. 32-35.
    
47. 
    Ерениев С.И., Генне Р.И., Семченко В.В., Степанов С.С., Особенности синаптоархитектоники конечного мозга человека при эпилепсии и эпилептическом синдроме. //Журн. невропатологии и психиатрии им.С.С. Корсакова, - 1990.- №10.-С.45-48.
    
48. 
    Ерениев С.И., Р.И. Генне, В.В. Семченко, С.С. Степанов //Особенности синаптоархитектоники конечного мозга человека при эпилепсии и эпилептическом синдроме// Журн. невропатолог. и психиатр. - 1990. - №10.- С.45-48.
    
49. 
    Жирмунская Е.А. Клиническая электроэнцефалография. - М., 1991. -77 с.
    
50. 
    Зенков Л.Р, Усачева Е.Л., Яхно Н.Н. Электрофизиологические и поведенческие корреляты нарушений школьной адаптации в исследовании условного негативного от-клонения при эпилепсии. В кн.: V Международная конференция и школа «Совре-менное состояние методов неинвазивной диагностики в медицине», 7-11 сентября 1998 г. - М. - 1998. - С. 193-195.
    
51. 
    Зенков Л.Р. Вальпроевая кислота в ретроспективе и перспективе //Неврологический журнал. - 2005. - Т. 10., №6. - С. 28-34.
    
52. 
    Зенков Л.Р. Взаимодействие противоэпилептических лекарств //Неврологический журн. 1999.-Т.4, № 32.-С.67-71.
    
53. 
    Зенков Л.Р. Кетогенная диета в лечении эпилепсии: обозрение по материалам журнала ”Epilepsia” за 1999-2000 гг. //Неврологический журн.-2000.-Т.5, №4.-С.24-28.
    
54. 
    Зенков Л.Р. Клиническая электроэнцефалография (с элементами эпилептологии). -, М. Медпресс. - 2004. – С.?
    
55. 
    Зенков Л.Р. Клиническая электроэнцефалография с элементами эпилептологии. - Таганрог, 1996.-112 с.
    
56. 
    Зенков Л.Р. Клиническая эпилептология (руководство для врачей). М. Медицинское информационное издательство. -2002. – С.?
    
57. 
    Зенков Л.Р. Компьютерные методы обработки в клинической электроэнцефалографии //Журн. невропатол. и психиатр. - 1990.-Т.90, №12.- С.103-109.
    
58. 
    Зенков Л.Р. Нелекарственные методы лечения эпилептических припадков //Журн. невропатол. и психиатр.- 1998.- Т.3, №1.-С.5-21.
    
59. 
    Зенков Л.Р. Патогенез и мультипараметрическая диагностика эпилептических и неэпилептических припадков //Terra media.-1997.-№6.-С.15-21.
    
60. 
    Зенков Л.Р. Патогенез и мультипараметрическая диагностика эпилептических и неэпилептических припадков. Ч. 2 //Terra medica. - 1998. - №4. - С. 44-46.
    
61. 
    Зенков Л.Р., Карлов В.А., Ронкин М.А., Гедекова А., Камышев А.Н. Возможности диагностики и оценки риска эпилепсии по данным спектрального анализа ЭЭГ у детей и подростков //Ж. невропатол. и психиатр. - 1989. — Т. 89., вып. 8. - С. 20-22.
    
62. 
    Зенков Л.Р., Ронкин М.А. Функциональная диагностика нервных болезней. - М.: Медицина, 1991.- 639 с.
    
63. 
    Иванов Э.В.Стереотаксический метод в диагностике и лечении височной эпилепсии. Дисс.… канд. мед. наук.- Свердловск, 1969.-20 с.
    
64. 
    Карлов В.А. IV Европейский конгресс по эпилептологии //Неврологический журн.-2001.-Т.6, №3.-С.21-23.
    
65. 
    Карлов В.А. Неврология: Руководство для врачей.- М.1999,- 634 с.
    
66. 
    Карлов В.А. Основные принципы терапии эпилептических припадков. //Неврологический журн.-1997.-Т.2, №5.-С.4-9.
    
67. 
    Карлов В.А. Современная концепция лечения эпилепсии //Журн. невропатол. и психиатр. -1999.-Т.99, №5.-С.12-18.
    
68. 
    Карлов В.А. Терапия нервных болезней.- М.,1996.-276 с.
    
69. 
    Карлов В.А. Эпилепсия как клиническая и нейрофизиологическая проблема //Журн. невропатол. и психиатр.-2000.-Т.100, №9.-С.18-20.
    
70. 
    Карлов В.А. Эпилепсия.- М.: Медицина, 1990.-335 с.
    
71. 
    Карлов В.А., Гнездицкий В.В. Абсансная эпилепсия у детей и взрослых. — «Прессервис». - М. - 2005. - ? с.
    
72. 
    Карлов В.А., Маджидов Н.М., Бова В.Е. /Джексоновский припадок. -Ташкент: Медицина, 1988.-143 с.
    
73. 
    Квитницкий-Рыжов Ю.Н., Матвиенко А.В. Современные представления о нейроглии головного мозга и ее реакциях на воздействие химических факторов (обзор) //Журн. невропатол. и психиатр.-1991.-Т.91, вып.3.- С.107-114.
    
74. 
    Коровин А.М., Савельева-Васильева Е.А., Чухловина М.Л. Перекисное окисление липидов при неврологических заболеваниях //Журн. невропатол. и психиатр.- 1991.- №8.- С.111-115.
    
75. 
    Коротнев Н.И., Минц В.М. Хирургическое лечение падучей //Русский врач.-1914.-Т.13.-С.472-476.
    
76. 
    Крылова В.Ю. Динамика показателей перекисного окисления липидов в процессе комплексной терапии эпилепсии у детей //Матер. XIX научн.-практ. конф. молодых ученых и специалистов КГИУВ. Киев,- 1991.- С.146-148.
    
77. 
    Кузьминова М.В. Изменения личности при эпилепсии //Рос. психиатр. журн. - 2000.-№3.-С.60-65.
    
78. 
    Лебедев А.А., Бурдаков В.В. Лечебный эффект антиагрегантов у больных вегетативно-сосудистой дистонией с начальными проявлениями недостаточности кровоснабжения мозга //Журн. невропатол. и психиатр. -1990.-№1.-С.48-52.
    
79. 
    Левицкий Д.О. Кальций и биологические мембраны. - М.: Медицина, 1990.-105 с.
    
80. 
    Асадуллаев М.М., О.М. Сысуев, Б.У. Ирискулов, Р.Б. Ходжаев //Некоторые аспекты патогенеза судорожного синдрома при церебральном лептоменингите// Неврология.- 2001.- №2.-С.65-67.
    
81. 
    Асадуллаев М.М., О.М. Сысуев, Г.С. Рахимбаева, Х.М. Маткулиев, И.А. Бикулова //Влияние перекисного окисления липидов на состояние функции слухового анализатора при церебральных лептоменингитах с судорожным синдромом// Истъедод. -1998. -№3. -С. 60-62.
    
82. 
    Максутова А., Фрешер В. Психофармакотерапия эпилепсии. Берлин-Вена,1998.-180 с.
    
83. 
    Малахов В.А., Кочуева Е.В. Сравнительная эффективность винпоцетина и танакана при монотерапии больных с начальными формами сосудистых заболеваний головного мозга //Фармакол. вiсник (Киев). – 1997. –С.50–52.
    
84. 
    Михайленко А.А., Иванов Ю.С., Семин Г.Ф. Ультразвуковая допплерография магистральных артерий головы и мозга в практике врача военного госпиталя: Учебн. пособие.- СПб, 1994.- 75 с.
    
85. 
    Мухин К.Ю., Петрухин А.С., Рыкова Е.А. Побочные эффекты антиконвульсантов при лечении идиопатической генерализованной эпилепсии //Журн. невропатол. и психиатр.-1997.-Т.97, №7.-С.26-30.
    
86. 
    Мякотных В.С.Динамика пневмоэнцефалографических изменений при фокальной эпилепсии //Журн. Невропатологии и психиатр.-1981.-№6.-С.868-873.
    
87. 
    Никушкин Е.В., Кучеряну В.Г., Крыжановский Г.Н. Перекисное окисление липидов при деполяризации синаптосом //Бюлл. экспер. биол.-1993.-№3.-С.244-246.
    
88. 
    Одинак М.М., Поздняков А.В., Тютин Л.А. Комплексная нейровизуализация гиппокампальной патологии при фармакорезистентных формах височной эпилепсии и ее роль в определении показаний к неинвазивному нейрохирургическому лечению //Матер. III съезда нейрохирургов России. -СПб, 2002.-С.473-474.
    
89. 
    Опарина Т.И., Голубев А.Г. О связи показателей интенсивности ПОЛ и содержания липидов в СМЖ больных эпилепсии //Бюлл. экспер. биол.-1994.-Т.117, №2.-С.215-217.
    
90. 
    Петрухин А.С. Нейропсихиатрические проблемы эпилепсии. //Неврологический журн.-1999.-Т.4, №6.- С.17-18.
    
91. 
    Поленов А.Л. Основы практической нейрохирургии.-Л.:Гос.изд-во мед.литературы, 1943.-548 с.
    
92. 
    Рачков Б.М. Ближайшие и отдаленные результаты хирургического лечения височной эпилепсии.- Дисс….докт. мед. наук. -Л.,1975.-355 с.
    
93. 
    Рейн Ф.А. Результаты оперативного лечения джексоновской эпилепсии и показания к нему //Хирургия.-1897.-№5.-С.378-414.
    
94. 
    Ромоданов А.П., Рябоконь Н.С., Божик В.П. Хирургическое лечение эпилепсии у детей.-Омск,1975.-С.160-162.
    
95. 
    С.И. Гаврилова, И.В. Колыхалов, И.М. Милопольская, М.А. Морозова, Н.Д. Селезнева //Танакан в лечении начальных проявлений церебрально–сосудистой недостаточности// Клин. геронтол. –1995. –№ 4. – С.22–23.
    
96. 
    Титов В.Н., Творогова М.Г. Диагностическое значение ионизированного кальция в крови //Клин. мед.-1992.-№9.-С.25-30.
    
97. 
    Тютин Л.С., Станжевский А.А. Современные возможности лучевой диагностики эпилепсии височной доли //Вестн. рентгенол. радиол. -2002.-№4.-С.54-62.
    
98. 
    Ходос Х.Г. Нервные болезни.- М.: МИА, 1999.-510 с.
    
99. 
    Шахнович А.Р., Шахнович В.А. Диагностика нарушений мозгового кровообращения. Транскраниальная допплерография.- М., -1996.- 446 с.
    
100. 
     Шершевер А.С. Динамика течения битемпоральной эпилепсии после хирургического лечения //Геронтология, гериатрия, послевоенная медицина: Матер. Межобл. научн.-практ. конф..-Екатеринбург,2002.-С.171-172.
     
101. 
     Шершевер А.С. Использование однофотонной эмиссионной компьютерной томографии в диагностике при хирургическом лечении эпилепсии. //Нейрохирургия и неврология детского возраста.-2004.-№1.-С.46-52.
     
102. 
     Шершевер А.С. Прогноз эпилепсии после операций на височной доле:Автореф.дисс.канд. мед. наук.-Л.,1984.-21 с.
     
103. 
     Шершевер А.С. Способ стереотаксической передней каллозотомии в лечении эпилепсии.-Патент на изобретение №22005600.-10 июня 2003.
     
104. 
     Шершевер А.С. Стереотаксическая передняя каллозотомия в лечении многоочаговой эпилепсии //Матер. IV Междун. симпоз. «Современные минимально-инвазивные технологии». -СПб, 2001.-С.462-464.
     
105. 
     Шмидт Е.В. Фармакотерапия эпилепсии.- Харьков, 1996.- 325 с.
     
106. 
     Шмидт Т.Е., Полунина А.Г., Хатиашвили И.Т. Эпилепсия: 100 элементарных принципов (Теодоре Р.Дж. Потер. Лондон, 161с.) //Неврологический журн.-1997.-№6.-С.23-26.
     
107. 
     Эмдин П.И. Новейшие принципы и методы хирургического вмешательства при эпилепсии //Проблема эпилепсии: Тр. Моск. обл. конф. -М.,1936.-С.219-224.
     
108. 
     Яхно Н.Н., И.В. Дамулин, В.В. Захаров, А.А. Скоромец, В.А. //Сорокоумов Применение танакана при начальных стадиях сосудистой мозговой недостаточности: результаты открытого мультицентрового исследования// Неврологический журн. –1998. –Т.З. –С.18–22.
     
109. 
     Яхно Н.Н., Штульман Д.Р., Мельничук П.В. Болезни нервной системы: Рук-во для врачей. - М., 1995.-Т.2.-С.280-314.
     
110. 
     Abou-Khalil B., Welch L., BlumenkopfB. etal. Global aphasia with seizure onset in the dom­inant basal temporal region // Epilepsia. - 1994. - V 35 - P. 1079-84.
     
111. 
     Adolphs R. Recognizing Emotion From Facial Expressions: Psychological and Neurological Mechanisms // Behav Cogn Neurosci Rev. - 2002. - V. 1 - P. 21-62.
     
112. 
     Aggleton J. P. The contribution of the amygdala to normal and abnormal emotional states. [Review] // Trends Neurosci. - 1993. - V. 16 - P. 328-333.
     
113. 
     Aicardi J. Epilepsy as a non-paroxysmal disorder // Acta Neuropediatr. - 1996. - V. 2 - P. 249-257.
     
114. 
     Aicardi J. Epileptic encephalopathies of early childood // Current Opinion in Neurology and Neurosurgery. - 1992. - V.5 - P. 344-348.
     
115. 
     Aicardi J. Epilepsy in children. New York: Raven Press, 1994.
     
116. 
     Akbarian S., Bunney J.E. Jr., Potkin S.G. et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenia implies disturbance of cortical development // Arch Gen Psychiatry. - 1993. - V. 50 - P. 169-177.
     
117. 
     Aldenkamp A. The effect of epilepsy and epileptic seizures on cognitive function // Factors affect­ing cognitive function in epilepsy // Eurocare UCB Disease Management. - 2000. - P. 2-7.
     
118. 
     Aldenkamp A., Bootsma H.-P. Cognitive side effects of antiepileptic drugs. In: Progress in epileptic disorders. V.l. Cognitive dysfunction in children with temporal lobe epilepsy. Arzimanoglou A., et al. (eds.). 2005, John Libbey Eurotext, Esher, Surrey, UK. - P. 217-232.
     
119. 
     Ames D., Cummings J.L., Wirshing W.C. et al. Repetitive and compulsive behavior in frontal lobe degenerations // J. Neuropsychiatry. Clin. Neurosci. - 1994. - V. 6 - P. 100-113.
     
120. 
     Anti–aggregatori effects of flavonoids in vivo and their influence on lypoxegenase and cycloxygenase in vitro /J. Swies, J. Robak, L. Dabrowski, Z. Duniec //Pol. J. Pharmacol. Pharm. –1994. –Vol.36. –P.455–463.
     
121. 
     Antochi R, Stavrakaki C, Emery P.C. Psychopharmacological treatments in persons with dual diagnosis of psychiatric disorders and developmental disabilities // Postgraduate Medical Journal. - 2003. - V.79 - P. 139-146.
     
122. 
     Arrigo A. Die Behandiung der chronischen zerebrovaskularen Insuffizienz mit Ginkgo biloba extrakt//Therapiewoche. –1986. –Vol.36.- P.5208–5218.
     
123. 
     Audenino D., Cocito L., Primavera A. Non-convulsive status epilepticus // Journal of Neurology Neurosurgery and Psychiatry. - 2003. - V.74 - P. 1599-1600.
     
124. 
     Auguet М., DeFeudis F.E., Clostre F. Effects of Ginkgo biloba on arterial smooth muscle responses to vasoactive stimuli //Gen. Pharmacol. – 1982. – Vol.13. –P.169–171.
     
125. 
     Austin J.K., Harezlak J., Dunn D.W. et al. Behavior Problems in Children Before First Recognized Seizures // Pediatrics. - V. 107. - P. 115-122.
     
126. 
     Babb T.L., Brown W.J. Neuronal, dendritic, and vascular profiles of human temporal lobe epilepsy correlated with cellular physiology in vivo // Adv Neurol. - 1986. - P. 949-966.
     
127. 
     Babb T.L., Kupfer W.R, Pretorius J.K. Synaptic reorganization of mossy fibers into molecu­lar layer in human epileptic fascia dentata // Abstracts of the Society for Neuroscience. - 1988.-V. 88-P. 351.
     
128. 
     Baldwin M., Bailey P. Temporal lobe epilepsy.-Springfield,IL:Charles C.Thomas,1958. - ? р.
     
129. 
     Ban W.B., Ashtari M., Bilder RM. et al. Brain morphometric comparison of first-episode schizophrenia and temporal lobe epilepsy//Br J Psychiatry. - 1997. - V. 170- P. 515-519.
     
130. 
     Barth D.S., Baumgartner Ch., Di Shi. Laminar interactions in rat motor cortex during cycli­cal excitability changes of the penicillin focus// Brain Res. - 1990. - V. 508. - P. 105-117.
     
131. 
     Bauer L.O., O'Connor S., Hesselbrock V.M. Frontal P300 decrements in antisocial personal­ity disorder//Alcohol: Clin Exp Res. - 1994. -V.l 8 - P. 1300-1305.
     
132. 
     Bauer U. Etude clinicue EGb 761 dans 1’artertedes members inferieurs. Essai a duble insu face au placebosur 6 mois //Arzneim Forsh Drug Res. –1984. –Vol.34, N6. –P.716–720.
     
133. 
     Beaumanoir A. The Landau-Kleffner syndrome. In: Roger J, Dravet C, Bureau M, Dreifus FE, Wolf P, eds Epileptic Syndromes in Infancy, Childhood and Adolescence London: John Libbey. - V. 1985 - P. 181-191.
     
134. 
     Beaumont A., Whittle I.R. The pathogenesis of tumour associated epilepsy//Acta Neurochir (Wien).- 2000.-Vol142,-P.1-15.//St.Zouis, Baltimore: Mosby, 1993.- 323 p.
     
135. 
     Beaussart M., Loiseau P., Roger J. The discovery of 'benign rolandic epilepsy' // Genetic of focal epilepsies: Clinical aspects and molecular biology. S.F.Bercovic, P.Genton, E. Hirsch and F.Picard 1999 John Libbey & Company Ltd. - P. 3-6.
     
136. 
     Bechara A., Damasio A.R., Damasio H., Anderson S. W. Insensitivity to future consequences following damage to human prefrontal cortex // Cognition. - 1994. - V. 50 - P. 7-12.
     
137. 
     Beers S.R., David RR, Elizabeth L.D. et al. Neuropsychological Study of Frontal Lobe Function in Psychotropic-Naive Children With Obsessive-Compulsive Disorder // Am.
     
138. 
     Behbehani M.M. Functional characteristics of the midbrain periaqueductal gray //Prog. Neurobiol. - 1995. - Vol. 46 - P. 575-605.
     
139. 
     Bemey T. Asperger syndrome from childhood into adulthood // Advances in Psychiatric Treatment. - 2004. - V.10 - P. 341-351.
     
140. 
     Ben-Ari Yehezekel. Cell death and synaptic reorganization produced by seizures // Epilepsia. - 2001. - V. 42, Suppl. 3 - P. 5-7.
     
141. 
     Benes EM. Altered glutamatergic and GABAergic mechanisms in the cingulate cortex of the schizophrenic brain //Arch Gen Psychiatry. - 1995. - V. 52 - P. 1015-1018.
     
142. 
     Berkovic S.E, Scheffer I.E. Genetic of partial epilepsies: new frontiers. In: Genetics of focal epilepsies: Clinical aspects and molecular biology. - 2000. - Berkovic S.F., Genton P., Picard F. John Libbey & Company Ltd. - P. 7-14.
     
143. 
     Berkovic S.F., Scheffer I.E. Epilepsies with single gene inheritance // Brain Dev. - 1997. - V. 19 - P. 13-18.
     
144. 
     Berndt E.D., Kramar M. Traiement medicamente ux des members inferieurs au stade 2b//Therapiewoche. –1984. –Vol.187, N37. –P.2815– 2819.
     
145. 
     Berney T.P. Autism - an evolving concept // The British Journal of Psychiatry. - 2000. - \fol. 176. - P. 20-25.
     
146. 
     Besag F.M.C. The EEG and learning disability. In: Trimble M.R. (Ed.). Learning disability and epilepsy: an integrative approach // Clarius Press Ltd. - 2003. - P. 122-131.
     
147. 
     Binnie CD. Significance and management of transitory cognitive impairment due to subclin­ical EEG discharges in children // Brain Dev. - 1993. - V. 15 - P. 23-30.
     
148. 
     Binnie CD., Marston D. Cognitive correlates of interictal discharges // Epilepsia. - 1992. - V. 33, Suppl. 6.-P. 11-17.
     
149. 
     Binnie D.B. Lamotrigine. In: Engel J, Pedley T.A., eds. Epilepsy. A comprehensive textbook. Philadelphia, New York: Lippencott-Raven, 1997 - P. 1531-1540.
     
150. 
     Biraben A., Taussigb D., Thomasd P. et al. Fear as the main feature of epileptic seizures // Neurol Neurosurg Psychiatry. - 2001. - V.70 - P. 186-191.
     
151. 
     Blackstock E.G. Cerebral asymmetry and the development of early infantile autism // J Autism Child Schizophr. - 1978. - V. 8 - P. 339-353.
     
152. 
     Blair R.J.R., Morris J. S., Frith CD. etal. Dissociable neural responses to facial expressions of sadness and anger//Brain. - 1999. - V.122. - P. 883-893.
     
153. 
     Blume W. Т., Pillay N. Electrographic and clinical correlates of secondary bilateral synchrony // Epilepsia. - 1985. - V. 26 - P. 636-641.
     
154. 
     Blume W.T. The EEG features of the Lennox-Gastaut syndrome. In: Niedermeyer E, Degan R, eds. The Lennox-Gastaut syndrome. New York: Alan R Liss, 1988. - V. 159-176.
     
155. 
     Bolton P. Developmental assessment//Advances in Psychiatric Treatment. - 2001. - V.7 - P. 32-40.
     
156. 
     Bolton P.F., Park R.J., Nicholas J. et al. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex//Brain. - 2002. -V. 125. - P. 1247-1255.
     
157. 
     Borgatti R, Zucca C, CavalliniA. etal. A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation // Neurology. - 2004. - V.63 - P. 57-65.
     
158. 
     Boshuisen M.L., Den Boer J.A. Zolmitriptan (5-ht receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder//Psychopharmacology.- 2000.-Vol.152, N1.-P.74-79.
     
159. 
     Bowden C.L., Calabrese Joseph R., Gary V.S. et al. A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder Arch Gen Psychiatry. 2003. - V.60 - P. 392-400.
     
160. 
     Bradley L.S., Jonathan W.M. Movement Disorders in Children Pediatr. Rev. - Feb 2003. - V. 24-P. 39-51.
     
161. 
     Brandao ML, Cardoso SH, Melo LL, Motta V, Coimbra NC. Neural substrate of defensive behavior in the midbrain tectum. [Review] // Neurosci Biobehav Revl994. - V. 18 - P. 339-46.
     
162. 
     Brinciotti M., Matricardi M., Paolella A. et al. Neuropsychological correlates of subclinical paroxysmal EEG activity in children with epilepsy, 1: qualitative features (generalized and focal abnormalities) // Functional Neurol. 1989. - V. 4 - P. 235-239.
     
163. 
     Brower M.C., Price B.H. Neuropsychiatry of frontal lobe dysfunction in violent and crimi­nal behaviour: a critical review // J. Neurol Neurosurg Psychiatry. - 2001. - V. 71 - P. 720-726.
     
164. 
     Buxhoeveden Daniel P., Casanova Manuel F. The minicolumn hypothesis in neuroscience // Brain. - 2002. - V. 125. - P. 935-951.
     
165. 
     Cahill H., Knipe S., McCann G.P. Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of hydroxytryptamine agonism //Clin. Sci.- 2000.-Vol.98, №6.-P.643-648.
     
166. 
     Callahan D.J., Noetzel M.J. Prolonged absence status epilepticus associated with car-bamzepine therapy, increased intracranial pressure and transient MRI abnormalities // Neurology. - 1992. - V. 42. - P. 2198-2201.
     
167. 
     Caraballo Ricardo., Cersosimo Carlos Medina, Fejerman Natalio. Panayiotopoulos-type benign childhood occipital epilepsy. A prospective study // Neurology. - 2000. - V. 55 - P. 1096-1100.
     
168. 
     Carpenedo R., Chiarugi A., Moroni F.Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and kynureninase //J. Neurochem.- 1996.-Vol. 67, №2.-P.692-698.
     
169. 
     Casanova Manuel F., Buxhoeveden Daniel, Gomez Juan. Disruption in the Inhibitory Architecture of the Cell Minicolummlmplications for Autisim // The Neuroscientist. - 2003. - V. 9. - P. 496-507.
     
170. 
     Casas-FemandezC, Belmonte-AvilesF, Fernandez-FernandezM.V. etal. Transient cognitive disorder from sub clinical paroxysmal EEG activity // Rev Neurol. - 2002. - V. 35, Suppl. 1. - P. S21-29.
     
171. 
     Centorrino F, Price B.H., Tuttle M. etal. EEG Abnormalities During Treatment With Typical and Atypical Antipsychotics // Am J Psychiatry. - 2002. - V.159 -P. 109-115.
     
172. 
     Ceresoli G.,Guidetti P., Schwarcz R. Metabolism of kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections //Brain Res.- 1997.-Vol.100,- №1.-P.73-81.
     
173. 
     Ceresoli-Borroni G., Schwarcz R. Perinatal kynurenine pathway metabolism in the normal and asphyctic rat brain// Amino Acids.- 2000.-Vol. 19.-N1.-P.311-323.
     
174. 
     Cerminara C, Montanaro M.L., Curatolo P. et al. Lamotrigine-induced seizure aggravation and negative myoclonus in idiopathic rolandic epilepsy // Neurology. - 2004. - V. 63 - P. 373-375.
     
175. 
     Chakrabarti S., Fombonne E. Pervasive Developmental Disorders in Preschool Children // JAMA. - 2001. - V. 285 - P. 3093-3099.
     
176. 
     Chamey D.S., Deutch A. A functional neuroanatomy of anxiety and fear: implications forthe pathophysiology and treatment of anxiety disorders // Crit Rev Neurobiol. - 1996. - V. 10 - P. 419-446.
     
177. 
     Chapman K., Holland K., Erenberg G. Seizure exacerbation associated with oxcarbazepine in idiopathic focal epilepsy of childhood // Neurology. - 2003. - V. 61 - P. 1012.
     
178. 
     Chez M., Buchanon С Age of regression of language and behaviour in children referred for pervasive developmental delay correlate to severity of epileptiform activity on 24 hour EEG. // Epilepsia. - 1997. - V. 38 (Suppl. 3). - P. 50.
     
179. 
     Chiarugi A., Carpenedo R., Moroni F. Kynurenine disposition in blood and brain of mice: effects of selective inhibitors of kynurenine hydroxylase and of kynureninase//J.Neurochem.- 1996.-Vol.67.-N2.-P692-698.
     
180. 
     Childs J.A., Blair J.L. Valproic acid treatment of epilepsy in autistic twins // J Neurosci Nurs. - 1997. - V. 29. - P. 244-248.
     
181. 
     Chugani D.C., Muzik O. Alfa-methyl –L-tryptophan PET maps brain serotonin synthesis and kynurenine pathway metabolism // Neuropharmacology.-1999.-Vol.38.-N8.-P.1225-1233.
     
182. 
     Chugani H. Т., Mazziotta J.C., Engel J., Phelps M.E. The Lennox-Gastaut syndrome: meta­bolic subtypes determined by 2-deoxy-2-fluro-D-glucose positron emission tomography // Ann Neurol. - 1987. - V. 21. - P. 4 -13.
     
183. 
     Chugani H. Т., Shields W.D., Shewmon DA. etal. I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment // Ann Neurol 1990. - V. 27. - P. 406-413.
     
184. 
     Chugani H.T., Da Silva E., Chugani D.C. Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomogrpahy // Ann Neurol. - 1996. - V. 39. - P. 643-649.
     
185. 
     Chugani H.T., Phelps M.E., Mazziotta J.C. Positron emission tomography study of human brain functional development // Ann Neurol. - 1987. - V. 22. - P. 487-497.
     
186. 
     Chugani H.T., Shewmon D.A., Sankar R., Chen B.C., Phelps M.E. Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomogrpahy // Ann Neurol. - 1992. - V 31. - P. 212-219.
     
187. 
     Citrome L., Jaffe A., Levine L. et al. Datapoints: Use of Mood Stabilizers Among Patients With Schizophrenia, 1994-2001 // Psychiatr Serv. - 2002. - Vol. 53. - P. 1212.
     
188. 
     Clostre F. De 1’organisme aux membranes cellulaires : lex differents niveuax d’actions pharmacologiques de 1’extrait de Ginkgo biloba//Presse Med. –1986. –Vol.15.- P.1529–1538.
     
189. 
     Porter R.J., B.S. Lunn, L.L. Walker, J.M. Gray, C.G. Ballard Cognitive deficit induced by acute tryptophan depletion in patients with Alzheimers disease //Amer. J. Psychiat.- 2000.-Vol.158, №4.-P.638-640.
     
190. 
     Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes // Epilepsia. - 1989. - V 30 - P. 389-399.
     
191. 
     Chiarugi A., Carpenedo R., M.T. Molina, R. Pellicciari, F. Moroni Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and /or kynureninase / //J. Neurochem. -1995.- Vol. 65.-№3.-P.1176-1183.
     
192. 
     Cookson J. Use of antipsychotic drugs and lithium in mania FRCPsych //The British Journal of Psychiatry. - 2001. - V.178 - P. sl48-sl56.
     
193. 
     Coppola G, Federico R., Auricchio G. et al. Levetiracetam as monotherapy in newly diagnosed benign rolandic seizueres in children: an open-label pilot trial // Epilepsia. - 2005. - V.46, Suppl. 6. - P. 102-103.
     
194. 
     Coppola G., Castaldo, P., Miraglia del Giudice E. et al. A novel KCNQ2 K+channel mutation in benign neonatal convulsions and centrotemporal spikes // Neurology. - 2003. -V. 61.-P.131-134.
     
195. 
     Courjon J., Cotte M.R. Les decharges pseudo-rythmiques localizees chez enfant et leur evo­lution a la puberte. 22eme Congres de Pediatrie de langue francaise. 1959. Montpellier: Dehan. - P. 247-250.
     
196. 
     Cramer J.A., Van Hamee G, Sadzot B. Positive impact of adjunctive levetiracetam health-related quality of life in patients with partial epilepsy. // Epilepsia. - 2005. - V.46, Suppl. 6. - P. 106-107.
     
197. 
     CukiertA., Forster C, Buratini J.A. et al. Secondary bilateral synchrony due to fronto-mesial lesions. An invasive recording study // Arq Neuropsiquiatr. - 1999. - V. 57. - P. 636-642.
     
198. 
     CummingsJ.L. Frontal-subcortical circuits and human behavior//Arch Neurol. - 1993. - P. 873-880.
     
199. 
     Cvetkovska E., Pashu M., VaskovT. et al. Correlative study of seizure control, EEG changes and improvement of cognitive performance and mood in epilepsy patients treated with lam­otrigine // Epilepsia. - 2004. - V 45. - Suppl. 3. - P. 136.
     
200. 
     Daffiier K.R., Mesulam M.M., Scinto L.F.M. et al. The central role of the prefrontal cortex in directing attention to novel events // Brain. - 2000. - V. 123. - P. 927 - 939.
     
201. 
     Damasio A.R. On some functions of the human prefrontal cortex // Ann NY Acad Sci 1995. - V 769. -P. 241-251.
     
202. 
     Damasio A.R., Tranel D., Damasio H. Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli // Behav Brain Res. - 1990. - V. 41.-P. 81-94.
     
203. 
     Damore J., Stine J., Brody L. Medication-induced hypomania in Asperger's disorder (letter) // J Am Acad Child Adolesc Psychiatry. - 1998. - V. 37. - P. 248-249.
     
204. 
     Davidson R.J., Irwin W. The functional neuroanatomy of emotion and affective style // Trends Cogn Sci. - 1999. - V. 3. - P. 11-21.
     
205. 
     De Marco P., Negrin P. Parietal focal spikes evoked by contralateral tactile somatotopic stim­ulation in four non-epileptic subjects // Electroencephalogr Clin Neurophysiol 1973. - V. 34. - P. 308-312.
     
206. 
     De Marco P., Tassinari C.A. Extreme somatosensory evoked potentials (ESEP): an EEG sign forecasting the possible occurrence of seizures in children // Epilepsia 1981. - V. 22. - P. 269-575.
     
207. 
     De Negri M., Doria L., Veneselli E. Acquired aphasia with epilepsy in the child // Neuropsychiat // Enfance adolesc. - 1983. - V. 31. - N 11-12. - P. 515-525.
     
208. 
     De Saint-Martin A.D., Seegmuller C, Carcangiu R. et al. Cognitive consequences of Rolandic Epilepsy // Epileptic Disord. - 2001. - V. 3 Spec No 2 - P. SI59-165.
     
209. 
     Deckel A W., Hesselbrock V., Bauer L. Antisocial personality disorder, childhood delinquen­cy, and frontal brain functioning: EEG and neuropsychological findings // J Clin Psychol 1996. - V. 52 - P. 639-50.
     
210. 
     Declan G.M. Murphy, Siew E. Chua. Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism // Brain. - doi:10.1093/brain/awh332.
     
211. 
     DeFeudis F.V. Endothelium–dependent vasorelaxation – a new basis for development cardiovascular drugs//Drugs Today. –1988. –Vol.24. –P.103– 115.
     
212. 
     Deisenhammer E. Transient global amnesia as an epileptic manifestation // J Neurol. 1981. - V. 225. - P. 289-292.
     
213. 
     Delia Bernardino В., Sgro V., Fejerman N. Epilepsy with centro-temporal spikes and related syndromes // Epileptic syndromes in Infancy, Childhood and Adolescence (3rd edn). J.Roger, Barbau M., Ch.Dravet, P.Genton, C.A.Tassinari & P.Wolf. 2002 John Libbey & Co Ltd, p.181-202.
     
214. 
     Deonna T. W. Acquired epileptiform aphasia in children (Landau-Kleffner syndrome) // J Clin Neurophysiol 1991. - V. 8. - P. 288-298.
     
215. 
     Deonna T.W., Roulet E., Fontan D., Marcoz J.P. Speach and oromotor deficits of epileptic origin in benign partial epilepsy of childhood with rolandic spikes: relationship to the acquired aphasia-epilepsy syndrome // Neuropediatrics. - 1993. - V.24. - P. 83-87.
     
216. 
     Deonna Т., BeaumanoirA., Gaillard F. Acquired aphasia in childhood with seizure disorder: a heterogeneous syndrome // Neuropadiatrie. - 1977. - V. 8. - P. 263-270.
     
217. 
     Deonna Т., Fletcher P., Voumard С Temporary regression during language acquisition: a lin­guistic analysis of a 2 1/2-year-old child with epileptic aphasia // Dev Med Child Neurol. - 1982. - V. 24. - P. 156-63.
     
218. 
     Devinsky O. Cognitive and behavioral effects of antiepileptic drugs // Epilepsia 1995. - V. 36, Suppl. 2. - P. 46-65.
     
219. 
     Devinsky O., Gershengom J., Brown E. et al. Frontal functions in juvenile myoclinic epilepsy // Neurol. Neuropsychol. Behav. Neurol. // 1997. - V 10. - P. 243-246.
     
220. 
     Devinsky O., Kelly K., PorterRJ., Theodore W.H.: Clinical and electroencephalograph^ fea­tures of simple partial seizures // Neurology. - 1988. - V. 43 - P. 1347-1352.
     
221. 
     Devlin, J.H., Harkness W., Chong W.K. et al. Clinical outcomes of hemispherectomy for epilepsy in childhood and adolescence. - Brain. - 2003. - V. 126. - P. 556-566.
     
222. 
     Dicks P., Myers R.E., KlingA. Uncus and amygdala lesions: effects on social behavior in the free-ranging rhesus monkey // Science. - 1969. - V. 165. - P. 69-71.
     
223. 
     Dinner D.S., Lueders H., Lederman R., Gretter Т.Е. Aphasic status epilepticus: a case report. - Neurology. - V. 31. - P. 888-891.
     
224. 
     Do-Hyung Kang, Jae-Jin Kim, Jung-Seok Choi et al. Volumetric Investigation of the Frontal -Subcortical Circuitry in Patients With Obsessive-Compulsive Disorder//J. Neuropsychiatry. Clin. Neurosci. - Aug 2004. - V. 16. - P. 342-349.
     
225. 
     Dolan R.J. On the neurology of morals//Nat Neurosci. - 1999. -V. 11. - P. 927-929
     
226. 
     DonatJ.F. The age-dependent epileptic encephalopathies //J Child Neurol 1992 - V7 - P. 7-21.
     
227. 
     Doose H, Baier W.K. Benign partial epilepsy and related conditions: multifactorial patho­genesis with hereditary impairment of brain maturation // Eur. J. Pediatr. - 1989. - V. 149.-P. 152-158.
     
228. 
     Doose H. Symptomatology in children with focal sharp waves of genetic origin // Eur. J. Pediatr. - 1989. - V.149. - P. 210-215.
     
229. 
     Dougherty D.D., Shin L.M., Alpert N.M. et al. Anger in healthy men: a PET study using script-driven imagery// Biol Psychiatry. - 1999. - V. 46. - P. 466-472.
     
230. 
     Dulac О. Epileptic encephalopathy //Epilepsia. - 2001. - Vol. 42, Suppl. 3. - P. 23-26.
     
231. 
     Dulac О. Epileptic encephalopathy//Epilepsia. - 2001. - V. 42, Suppl 3. - P. 23-26.
     
232. 
     Eastman C.L., Guilarte T.R. Cytotoxicity of hydroxykynurenine in a neuronal hybrid cell line// Brain Res.- 1989.-Vol.495.-N2.-P.225-231.
     
233. 
     EchenneB, Cheminal R, RivierF. Epileptic electroencephalographic abnormalities and devel­opmental dysphasias: a study of 32 patients // Brain Dev. - 1992. - V. 14. - P. 216-225.
     
234. 
     Eckmann F., Schlag H. Kontrolierte Doppelblind–Studiezum Wirkzamkeitsnachweis von Tebonin forte bei Patienten mit zerebrovaskularer Insuffizienz//Fortschr Med. –1982. –Bd.100.–S.1474–1478.
     
235. 
     Eeg-Olofsson O. The genetics of benign childhood epilepsy with centrotemporal spikes. In: Genetics of focal epilepsies: Clinical aspects and molecular biology. - 2000. - Berkovic S.F., Genton P., Picard F. John Libbey & Company Ltd. - p.p. 35-41.
     
236. 
     Eeg-Olofsson O., Petersen I., Selden U. The development of the electroencephalogram in nor­mal children from the age of one throug 15 years // Neuropediatrics. - 1971. - V. 2. - P. 374-404.
     
237. 
     Sram R.J., Binkova B., Stejskalova J., Topinka J., Ferradini C., M.T. Droy–Lefaix, Y. Christen (eds). Effect of Egb 761 on lipid peroxidation, DNA repair and antioxienzyme activity / Ginkgo biloba extract as free radical scavenger /Advances in Gink о biloba Extract Research. –1993. – Vol.2.–P.27–38.
     
238. 
     Deby C., G. Deby–Dupont, M. Dister, J. Pincmail / C.Feraadini, M.T.Droy–Lefaix, Y.Christen (eds). //Efficiency of Ginkgo biloba extract (EGb 761) in neutralizing ferrylion–induced peroxidations: therapeutic implications Ginkgo biloba extract as free radical scavenger //Advances in Ginkgo biloba Extract Research. –1993. –Vol.2.–P.13–26.
     
239. 
     Einfeld S.L. Systematic management approach to pharmacotherapy for people with learning disabilities // Advan. Psychiatr. Treat. - Jan 2001. - V. 7 - P. 43-49.
     
240. 
     Elliott F.A. Violence. The neurologic contribution: an overview // Arch Neurol. -1992. - 49 - P. 595-603.
     
241. 
     Elliott FA. Neurology of aggression and episodic dyscontrol // Semin Neurol 1990. - V. 10 - P. 303-312.
     
242. 
     Kamata K., T. Mori, K. Shigenobu, R. Kasuya//Endothelium–dependent vasodilatation effects of platelet activation factor on rat resistance vesselsBrit. J. Pharmacol.–1989. –Vol.98.–P.1360–1364.
     
243. 
     Engel J Jr, Bandler R, Griffith NC, Caldecott-Hazard S: Neurobiological evidence for epilep­sy-induced interictal disturbances, in Neurobehavioral Problems in Epilepsy: Advances in Neurology, vol 55. Edited by Smith D, Treiman D, Trimble M. New York, Raven Press, 991, pp. 97-111.
     
244. 
     Engel J. Jr, Caldecott-Hazard S, Bandler R. Neurobiology of behavior: anatomic and physiologic implications related to epilepsy //Epilepsia. — 1986. — Vol. 27, Suppl. 2.-P. S3-S13.
     
245. 
     Engel J., Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology //Epilepsia. — 2001. —Vol. 42. - P. 796-803.
     
246. 
     Eriksson K, Kyllianen A., Hirvonen К etal. Visual agnosia in a child with non-lesional occip-ito-temporal CSWS // Brain Dev. - 2003. - V 25. - P. 262-267.
     
247. 
     Eriksson K,. Kylliainen A., Hirvonen К Etal. Viaual agnosia with occipital CSWS-A Landau-Kleffner equivalent? // Epilepsia. - 2000. - V. 41, Suppl. 7. - P. 195.
     
248. 
     Israel L., E. Dell’Accio, G. Martin, R. Hugonot//Extrait de Ginkgo biloba et expercises d’entrainement de la memoire. Evaluation comparative chez des personnes agees ambulatoiresPsychol Med. –1987. –Vol.19.-P.1431–1439.
     
249. 
     Feely Morgan, Drug treatment of epilepsy Topiramate // BMJ. - 1999. - V. 318. - P. 106-109.
     
250. 
     Feme CD., Madigan C, Tilling K. et al. Adaptive and maladaptive behaviour in children with epileptic encephalopathies: correlation with cerebral glucose metabolism // Dev Med Child Neurol. - 1997. - V. 39. - P. 588-595.
     
251. 
     Fenwick P. The use of magnetocencephalography in neurology, in Advances in Neurology, vol 54: Magnetoencephalography. Edited by Sato S. New York, Raven Press, 1990 - P. 271-282.
     
252. 
     Ferrie CD., Maisey M., Cox T. et al. Focal abnormalities detected by FDG PET in epileptic encephalopathies // Arch Dis Child. - 1996. - V. 75. - P. 102-107.
     
253. 
     Ferrie CD., Marsden P.K., Maisey M.N., Robinson R.O. Cortical and subcortical glucose metabolism in childhood epileptic encephalopathies // J Neurol Neurosurg Psychiatry. - 1997. - V. 63. - P. 181-187.
     
254. 
     Filipek P.A., Accardo P.J., Ashwal S. et al. Positron emission tomography in two cases of childhood epileptic encephalopathy (Lennox-Gastaut syndrome) // Neurology. - 1982. - V. 32-P. 1191-1194.
     
255. 
     Finn P.R., Ramsey S.E., Earleywine M. Frontal EEG response to threat, aggressive traits and a family history of alcoholism: a preliminary study // J Stud Alcohol. - 2000. - V. 61. - P. 38-45.
     
256. 
     Fishbein D.H., Heming R.I., Pickworth W.B., et al. EEG and brainstem auditory evoked response potentials in adult male drug abusers with self-reported histories of aggressive behavior// Biol Psychiatry 1989. - V. 26. - P. 595-611.
     
257. 
     Fisher R.S., van Emde Boas W., Blume W. et al. Epileptic seizures and Epilepsy: Definitions proposed by the International League Against Epilepsy (ILAE) // Epilepsia. - 2005. - V.46. - P. 470-472.
     
258. 
     Folz E.L., White L.E. Pain «relief» by frontal cingulotomy // J. Neurosurg. - 1962. - V. 19. - P. 89-100.
     
259. 
     Frazier J.A., Doyle R., Chiu S., Coyle J.T. Treating a child with Asperger's disorder and comorbid bipolar disorder // Am J Psychiatry. - 2002. - V. 159. - P. 13-21.
     
260. 
     Manjarrez G., J.L. Contreras, G. Chagoya, R.J. Hernandez //Free tryptophan as an indicator of brain serotonin synthesis in infants Pediatr. Neurol.-1998. –Vol.18, N1.-P.57-62.
     
261. 
     Freedman R., Coon H., Myles-Worsley M. et al. Linkage of a neurophysiologies deficit in schizophrenia to a chromosome 15 locus // Proc Natl Acad Sci USA. - 1997. - V. 94. - P. 587-592.
     
262. 
     Friedman J.H. Chapter 3. Mood, emotion, and Thought // Textbook of clinical neurology / [edited by] Christopher G. Goetz. - 2nd ed. - 2003. - P. 33-52.
     
263. 
     FritzN.E., ElgerC.E., Helmstaeder E. Effect of an add-on treatment with topiramate of lev-etiracetam on cognition and health related quality of life for patients with epilepsy. // Epilepsia. - 2005. - V.46, Suppl. 6. - P. 106-107.
     
264. 
     Gaillard W.D., Hertz-Pannier L., Mott S.H. et al. Functional anatomy of cognitive develop­ment. fMRI of verbal fluency in children and adults //Neurology. - 2000. - V. 54. - P. 180.
     
265. 
     Gallagher M., Chiba A.A. The amygdala and emotion. [Review] // Curr Opin Neurobiol. - 1996.-V. 6.-P. 221-227.
     
266. 
     Gallhofer В., Trimble M.R., Frackowiak R. et al. A study of cerebral blood flow and metabo­lism in epileptic psychosis using positron emission tomography and oxygen // J Neurol Neurosurg Psychiatry. - 1985. - V. 48 - P. 201-206.
     
267. 
     Gallinat J., Hegerl V. Limbic ictus as a condition for anxiety attacks // Nervenarzt. - 1999.-V. 70.-P. 206-215.
     
268. 
     Garcia-Flores E. Corpus Callosotomy for the Treatment of Landau-Kleffner Synrome // Epilepsia. - 1999. - V. 40. - Suppl. 2. - P. 62.
     
269. 
     Garcia-Penas J.J. Antiepileptic drugs in the treatment of autistic regression syndromes // Rev Neurol. - 2005. - V. 40, Suppl 1. - P. S173-176.
     
270. 
     Garret R.H., Grisham C.M. Molecular aspects of Cell Biology. -Philadelphia: Saunders College Publ.-1995.-P.1227-1243.
     
271. 
     Gastaut H. Benign epilepsy of childhood with occipital paroxisms // Roger J., Bureau M., Deifuss F.E., Wolf P. (eds.). Epileptic syndromes in infancy, childhood and adolescence. London: John Libbey. - 1985. - P. 159-170.
     
272. 
     Gastaut H. Colloque sur les problems d’anatonmie normale et patolologique pose par les decharges epileptiques //Acta Med. Belg.-Suppl.1954. P ?
     
273. 
     Gastaut H., Zifkin B.G., Mariani E., Puig J.S. The long-term course of primary generalized epilepsy with persisting absences // Neurology. - 1986. - V. 36. - P. 1021-1028.
     
274. 
     Gastaut H.et al.Colloque sur les problems d’anatonmie normale et patolologique pose par les decharges epileptiques //Acta Med.Belg.-Suppl.1954.
     
275. 
     Gastaut Y. Un element deroutant de la semiology electroencephalographique: les points pre-rolandique sans signification focale // Rev. Neurol. (Paris). - 1952. - V.87. - P. 488-490.
     
276. 
     Gedye A. Episodic rage and aggression attributed to frontal lobe seizures // Journal of Mental Deficiency Research. - 1989. - V. 33. - P. 369-79.
     
277. 
     George M.S., Ketter T.A., Parekh PL, Horwitz В., Herscovitch P., Post R.M. Brain activity during transient sadness and happiness in healthy women // Am J Psychiatry. - 1995. - V 152.-P. 341-351.
     
278. 
     Gessner В., Volp А., Klasser М. Study of the long–term action of a Ginkgo biloba extract on vigilance and mental perfomance as determined by means of quantative pharmaco–EEG and psychometric measurements //Arzneim Forsch Drug Res. –1985. –Vol.2.–P.35-40.
     
279. 
     Ghaemi S.N., Boiman E.E., Goodwin F.K. Kindling and second messengers: an approach to the neurobiology of recurrence in bipolar disorder. - Biol Psychiatry 1999. - V 45. - P. 137-144.
     
280. 
     Giancola P.R., Zeichner A. Neuropsychological performance on tests of frontal-lobe func­tioning and aggressive behavior in men // J Abnorm Psychol 1994. - V. 103. - P. 832-835.
     
281. 
     Gibbs E.L., Gillen H.W., Gibbs F.A. Disappearance and migration of epileptic foci in child­hood // Am. J. dis. child. - 1954. - V. 88. - P. 596-603.
     
282. 
     Gibbs F.A., Gibbs E.L. Atlas of electroencephalography. - 1952. - V. 2. Reading, MA: Addison-Wesley.
     
283. 
     Gilbert G.J. Transient global amnesia: manifestation of medial temporal epilepsy // Clin Electroencephalogr. - 1978. - V. 9. - P. 147-152.
     
284. 
     Gillberg C, Uverbrant P., Carlsson G, Hedstrom A., Silfvenius H. Autism and epilepsy (and tuberous sclerosis?) in two pre-adolescent boys, neuropsychiatric aspects before and after epilepsy surgery//J Intellect Disabil Res. - 1996. - V. 40. - P. 75-81.
     
285. 
     Gillberg, C, Schaumann, H. Epilepsy presenting as infantile autism? Two case studies // Neuropediatrics - 1983. - V. 14. - P. 206 -212.
     
286. 
     Gilliam F., Kanner A.M. Treatment of depressive disorders in epilepsy patients. - Epilepsy Behav. - 2002. - V. 3. - P. 2-9.
     
287. 
     Packer L., N. Haramaki, J. Kawabata /Y. Christen, Y. Courtois, M.T. Droy–Lefaix (eds). Gingko biloba extract (EGb 761): antioxidant action and prevention of oxidative stress–induced injuryEffects of Ginkgo biloba extract (EGb 761) on agi g and age– related disorders//Advances in Ginkgo biloba Extract Research. –1995.–Vol.4. – P.23–48.
     
288. 
     Glick I.D., Suppes Т., DeBattista С et al. Psychopharmacologic Treatment Strategies for Depression, Bipolar Disorder, and Schizophrenia //Ann Intern Med. - 2001. - V. 134. - P. 47-60.
     
289. 
     Gloor P. Neurobiological substrates of ictal behavioral changes, in Neurobehavioral Problems in Epilepsy: Advances in Neurology, vol 55. Edited by Smith D, Treiman D, Trimble M. New York, Raven Press, 1991. - P. 1-34.
     
290. 
     Gordon N. The Landau-Kleffner syndrome: increased understanding // Brain Dev 1997. - V. 19.-P. 311-316.
     
291. 
     Goyer P.F., Andreason P.J, Semple W.E. et al. Positron-emission tomography and personali­ty disorders // Neuropsychopharmacology. - 1994. - V. 10. - P. 21-28.
     
292. 
     Grafman J., Litvan I. Importance of deficits in executive functions // Lancet. - 1999. - V. 354. - P. 1921-1923.
     
293. 
     Grafman J., Schwab K., Warden D. et al. Frontal lobe injuries, violence, and aggression: a report of the Vietnam Head Injury Study // Neurology. - 1996. - V. 46. - P. 1231-1238.
     
294. 
     Graitme M. McAlonan, V. Cheung, C. Cheung. Mapping the brain in autism. A voxel-based MR1 study of volumetric differences and intercorrelations in autism Brain, doi:10.1093 /brain /awh332.
     
295. 
     Graitme M. McAlonan, Vinci Cheung, Charlton Cheung et al. Mapping the brain in autism. A voxel-based MR1 study of volumetric differences and intercorrelations in autism Brain, doi:10.1093/brain/awh332.
     
296. 
     Green A.R., Curson G. The effect of tryptophan metabolites on brain hydroxytriptamine metabolism//Biochem. Pharmacol.-1980.-Vol.19, N6.- P.2061-2068.
     
297. 
     Greenberg B.D., Ziemann U., Cora-LocatelliG. etal. Altered cortical excitability in obsessive-compulsive disorder// Neurology. - 2000. - V. 54. - P. 142.
     
298. 
     Grimes D.A., Guberman A. De novo aphasic status epilepticus // Epilepsia. - 1997. - V. 38. - P. 945-949.
     
299. 
     Gross-Selbeck G. Treatment of «benign» partial epilepsies of childhood, including atypical forms // Neuropediatrics. - 1995. - V. 26. - P. 45-50.
     
300. 
     Gross-Tsur V., Shalev R.S., Manor 0., Amir N. Developmental right-hemisphere syndrome: clinical spectrum of the nonverbal learning disability // J. Learn Disabil. - 1995. - V. 28. - P. 80-86.
     
301. 
     Gross-Tsur V., Shalev Ruth S. Reversible language regression as an adverse effect of topira-mate treatment in children // Neurology. - V 62. - P. 299-300.
     
302. 
     Grote C.L., Van Slyke P., Hoeppner J.A. Language outcome following multiple subpial tran­section for Landau Kleffner syndrome // Brain. - 1999. - V. 122. - P. 561-566.
     
303. 
     Guerreiro M.M., Camargo E.E., Kato M. Brain single photon emission computed tomography imaging in Landau - Kleffner syndrome // Epilepsia. - 1996. - V. 37. - P. 60-67.
     
304. 
     Guipponi M., Vigevano F., EchenneB., MalafosseA. Gene mapping for benign infantile famil­ial convulsions. In: Genetics of focal epilepsies: Clinical aspects and molecular biology. - 2000. - Berkovic S.F., Genton P., Picard F. John Libbey & Company Ltd. - P. 69-72.
     
305. 
     Gusel W.A. Relationships between kynurenine and serotonin pathways and antiepileptic treatment strategies//International study group for tryptophan research.- Baltimore,1989.-P.43.
     
306. 
     Habib Michel. The neurological basis of developmental dyslexia. An overview and working hypothesis. - Brain. - 2000. - V. 123. - 2373-2399.
     
307. 
     Halama P. Was leistet der Spezialextrakt (Egb 761) //Therapiewoche. –1990. –Vol.40. –P.3760–3765.
     
308. 
     Halama P., Bartsch G., Meng G.. Hirnleistungstorungen vaskularer Genese. Randomisierte Doppelblindstudie zur Wirksamkeit von Ginkgo–biloba Extrakt //Fortschr Med. –1988. –Bd.106. –S.402–412.
     
309. 
     Halasz P., Kelemen A., Clemens B. et al. The perisylvian epileptic network. A unifying con­cept // Ideggyogy Sz - 2005. - V. 58. - P. 21-31.
     
310. 
     Halgren E. Emotional neurophysiology of the amygdala within the context of human cogni­tion. In: Aggleton JP, editor. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss. - V. 1992. - P. 191-228.
     
311. 
     Hamano S., Mochizuki M., Morikawa T. Phenobarbital-induced atypical absence seizure in benign childhood epilepsy with centrotemporal spikes // Seizure. - 2002. - V 11. - P. 201-204.
     
312. 
     Hamano Т., Luders H.O., Ikeda A. et al. The cortical generators of the contingent negative variation in humans: a study with subdural electrodes // Electroencephalogr Clin Neurophysiol. - 1997. - V. 104. - P. 257-268.
     
313. 
     Harris John Т., Roache John D., Thornton Joseph E. A role for valproate in the treatment of sedative-hypnotic withdrawal and for relapse prevention // Alcohol and Alcoholism. - 2000. - V.35. - P. 319-323.
     
314. 
     Haverkamp F., Hanisch C, Mayer H, Noeker M. Evidence of a specific vulnerability for defi­cient sequential cognitive information processing in epilepsy // J Child Neurol. - 2001. -V. 16. - P. 901-905.
     
315. 
     Heath R.G. Common clinical characteristics of epilepsy and schizophrenia: clinical observa-tion and depth electrode studies //Am. J. Psychiatry. - 1962. - Vol. 118. - P. 1013-1026.
     
316. 
     Hendriks M.P.H., Scholtes F.B.J. Neuropsychological Profiles of 11 Children with Continuous Spikes and Waves During Sleep (CSWS). A Clinical Follow-Up // Epilepsia. - 1999. - Vol. 40, Suppl. 2. - P. 165.
     
317. 
     Hermann B.P., Dikmen S., Schwartz M.S., Karnes W.E. Interictal psychopathology in patients with ictal fear: a quantitative investigation // Neurology. - 1982. - V. 32. - P. 7-11.
     
318. 
     Hertz-Pannier L., Chiron Catherine, Jambaqu Isabelle et al. Late plasticity for language in a child's non-dominant hemisphere. A pre - and post-surgery fMRI study. - Brain. - 2002. -V.125. - P. 361-372.
     
319. 
     Hian-Tat Ong, Wyllie Elaine. Benign childhood epilepsy with centrotemporal spikes: Is it always benign? - Neurology. - 2000. - V. 54. - P. 1182-1185.
     
320. 
     Hilty Donald M., Rodriguez Gerardo D., Hales R.E. Treatment of Comorbid Bipolar Disorder and Epilepsy With Valproate // J. Neuropsychiatry. Clin. Neurosci. - May 2000. - V. 12. - P. 283-85.
     
321. 
     Hiratani M. Electrical status epilepticus during sleep(ESES). Different clinical syndromes: towards a unifying view //Brain Dev. – 1997.-Vol.19, №7. P.447-451.
     
322. 
     Hirsch Lawrence J., Emerson Ronald G., Ped/ey Timothy A., Prolonged «postictal» aphasia: Demonstration of persistent ictal activity with intracranial electrodes // Neurology. - 2001.-V. 56. -P. 134-136.
     
323. 
     Hodges J.R., Warlow C.P. The aetiology of transient global amnesia: a case control study of 114 cases with prospective follow-up // Brain. - 1990. - V. 113. - P. 639-657.
     
324. 
     Hofferberth B. The efficacy of Egb 761 in patients with senile dementia of the Alzheimer type, a, double blind placebo–controlled study on different level of investigation//Hum. Psychopharmacol. –1994. – Vol.9. –P.215–222.
     
325. 
     Holdago Madruga M., De Castro S., Macias–Nunez J.F. Effects of Ginkgo biloba extract (Egb 761) ob brain aging and oxygen free radicals metabolism in rat/Y. Christen, Y. Courtois, M.T. Droy–Lefaix (eds). Effects of Ginkgo biloba extract (EGb 76 ) on aging and age– related disorders//Advances in Ginkgo biloba Extract Research.–1995.Vol.4 –P.71–76.
     
326. 
     Holmes G.L., McKeever M., Saunders Z. Epileptiform activity in aphasia of childhood: an epiphenomenon? // Epilepsia. - 1981. - V. 22. - P. 631-639.
     
327. 
     Huck F.R., Radvany J., Avila J.O., Pires de Camargo C.H. et al. Anterior callosotomy in epileptics with multiform seizures and bilateral synchronous spike and wave EEG pattern // Acta Neurochir Suppl (Wien). - 1980. - V 30. - P. 127-135.
     
328. 
     Hurley Robin A., Lewine J.D., Jones G.M. et al. Application of Magnetoencephalography to the Study of Autism // J. Neuropsychiatry. Clin. Neurosci. - 2000. - V. 12. - P. 1-3.
     
329. 
     Hurt R. W., Ballantine H. T. Stereotactic anterior cingulate lesions for persistent pain: a report of 68 cases // Clin. Neurosurg. - 1973. - V 21. - P. 334-351.
     
330. 
     Iivanainen M., Bergstrom L., Nuutila A., Viukari M. Psychosis-like absence status of elderly patients: successful treatment with sodium valproate // Journal of Neurology, Neurosurgery, and Psychiatry. - 1984. - V.47. - P. 965-969.
     
331. 
     Carpenedo R., A. Chiarugi, P. Russi, G. Lombardi, V. Carla, L. Mattoli9//Inhibitors of kynurenine hydroxylase and kynureninase increase cerebral formation of kynurenate and have sedative and anticonvulsant activitiesNeuroscience.- 1994.Vol. 61, N2.-P.237-243.
     
332. 
     Itil T.M., Soldatos С Epileptogenic side effects of psychotropic drugs // JAMA. - 1980. - V.244. - P. 1460-1463.
     
333. 
     Ivanova N.A., Nikitina Z.S. Elevated kynurenine concentration in the blood serum of children with epilepsy and bronchial asthma //Psychopharmacology (Berl.).- 1995.-Bd.119. №3.-S.247-260.
     
334. 
     Jambaqu I., Mottron L., Ponsot G. // Chironc Autism and visual agnosia in a child with right occipital lobectomy // J Neurol Neurosurg Psychiatry. - 1998. - V. 65. - P. 555-560.
     
335. 
     Janssen-Silag. Topamax. Product monograph. 1996.
     
336. 
     Janszky J., Jokeit H., Heinemann D. et al. Epileptic activity influences the speech organiza­tion in medial temporal lobe epilepsy// Brain. - 2003. - V.126. - P. 2043-2051.
     
337. 
     Janszky J., Ollech I., Jokeit H. et al. Epileptic activity influences the lateralization of mesiotemporal fMRI activity// Neurology. - 2004. - V. 63. - P. 1813-1817.
     
338. 
     Johnston M. V. Neurotransmitters and epilepsy. In: Wyllie E, ed. The treatment of epilepsy: principles and practice. Philadelphia: Lea and Febiger, 1993. - V. 111-125.
     
339. 
     Jokeit H, Daamen M., Zang H. et al. Seizures accelerate forgetting in patients with left-sided temporal lobe epilepsy// Neurology. - 2001. - V. 57. - P. 125 - 126.
     
340. 
     Joseph M.N., Risby D. The determination of kynurenine in plasma//Clin. Chim. Acta.- 1975.-Vol.63, N2.-P.197-204.
     
341. 
     Jung K. Y, Kim J.M., Kim D. W., Chung C.S. Independent component analysis of generalized spike-and-wave discharges: primary versus secondary bilateral synchrony // Clin Neurophysiol. - 2005. - V. 116. - P. 913-919.
     
342. 
     Kallen Ronald J. A Long Letter and an Even Longer Reply About Autism Magnetoencephalography and Electroencephalography // Pediatrics. - 2001. - V.107. - P. 1232-1235.
     
343. 
     Kanemoto K., Kawasaki J., Kawai J. Postictal psychosis: a comparison with acute interictal and chronic psychoses // Epilepsia. - 1996. - V 37. - P.551-556.
     
344. 
     Kanner Andres M., Balabanov Antoaneta. Depression and epilepsy: How closely related are they? // Neurology. - 2002. - V. 58. - P. 27 - 39.
     
345. 
     Kaplan P. Prognosis in nonconvulsive status epilepticus//Epileptic Disord. -2000.-Vol.2, N4.-P.185-194.
     
346. 
     Kaplan P. Prognosis in nonconvulsive status epilepticus //Epileptic Disord. -2000.-Vol.2, №4.-P.185-194.
     
347. 
     Kapoor V.,Kapoor R., Chalmers J. Kynurenic acid, an endogenous glutamate antagonist, in SHR and WKY rats: possible role in central blood pressure regulation//Clin. Exp. Pharmacol. Physiol.- 1994.-Vol.21, N11.-P.891-896.
     
348. 
     Kawasaki Y, Yokota K., Shinomiya M. et al. Electroencephalographic paroxysmal activities in the frontal area emerged in middle childhood and during adolescence in a fol­low-up study of autism // Journal of Autism and Developmental Disorders. - 1997. - V.27. - P. 605 -620.
     
349. 
     KendrickJ.F., Gibbs FA. Origin, spread and neurosurgical treatment of the psychomotor type of seizure discharge // J Neurosurg. - 1957. - V. 14. - P.270-284.
     
350. 
     Khatami R., Grosse P., Hoffmann K.-T., Venz S., Schmitz B. Treatment of Nonconvulsive Status Epilepticus with Topiramate // Epilepsia. - 1999. - V. 40, Suppl. 2. - P. 285.
     
351. 
     Kim Edward, Humaran Teresa J. Divalproex in the Management of Neuropsychiatry Complications of Remote Acquired Brain Injury // J Neuropsychiatry Clin Neurosci. - 2002. - V.14 - P. 202-205.
     
352. 
     Klaassen T., Riedel W.J., Van Someren A. Specificity of the tryptophan depletion method //Psychopharmacology.-1999.-Vol.141, №3.-P.279-86.
     
353. 
     Kleijnen J., Knipschild P. Ginkgo biloba//Lancet.–1992. –Vol.340, N7.–P.1136–1139.
     
354. 
     Kling A.S., Brothers L.A. The amygdala and social behavior. In: Aggleton J.P., editor. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss. - 1992. - P. 353-377.
     
355. 
     Koft J. Clinical chemistry of monoamins, S.-Francisco, 1984.- 94 p.
     
356. 
     Koutroumanidis Michael, Binnie Colin D., Elwes Robert D. et al. Interictal regional slow activ­ity in temporal lobe epilepsy correlates with lateral temporal hypometabolism as imaged with 18FDG PET: neurophysiological and metabolic implications // J Neurol Neurosurg Psychiatry. - 1998. - V. 65. - P. 170-176.
     
357. 
     Kozik A. Localization and lateralization of epileptic foci in children. An analysis of spike mapping // Epileptologia. - 2005. - V.13, Suppl. 1. - P. 108.
     
358. 
     Kramer U., Nevo Y, Neufeld M.Y. Epidemiology of epilepsy in childhood: a cohort of 440 consecutive patients // Pediatr Neurol. - 1998. - V. 18. - P. 46-50.
     
359. 
     Kunkel H. Comparative study on the EEG active spectrum of Tebonin (80 mg) and two partial extracts- Karlsruhe, 1989.
     
360. 
     Kutschke G, Brodbeck V., BoorR., Reitter B. Do subclinical epileptic discharges (SED) influ­ence language functions in children with developmental language disorder (DLD)? // Epilepsia. - 1999. - V. 40. - Suppl. 2. - P. 20.
     
361. 
     Kwan P., Brodie M.J. Potential role of drug transporters in the pathogenesis of medically intractable epilepsy // Epilepsia. - 2005. - V. 46. - P. 224-235.
     
362. 
     Kwan P., Brodie M.J. Refractory epilepsy: a progressive, intractable but preventable condi­tion? // Seizure. - 2002. - V. 11. - P. 77-84.
     
363. 
     Kynurenine pathway enzymes in a rat model of chronic epilepsy: immunohistochemical study of activated glial cells/J. Williamson, E. Bertram, E. Lothman, R. Okuno// J. Neurosci.- 1993.-Vol.55, N4.-P.975-989.
     
364. 
     LabateA., Briellmann R.S., Scheffer I.E. etal. Amygdala dysplasia with temporal lobe epilep­sy and obsessive-compulsive disorder: An fMRI/EEG study // Neurology. - 2005. - V. 64. -P. 1309- 1310.
     
365. 
     Laeng P., Pitts R.L., Lemire A.L. et al. The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cells//J. Neurochem. - 2004. - V. 91. - P. 238-251.
     
366. 
     Landau W.M. Landau-Kleffner syndrome. An eponymic badge of ignorance // Arch Neurol. - 1992. - V. 49. - P. 353.
     
367. 
     Landau W.M., Kleffner F.R. Syndrome of acquired aphasia with convulsive disorder in chil­dren // Neurology. - 1957. - V. 7. - P.523-530.
     
368. 
     Landau Y.E., Auerbach J.G., Gross-Tsur V., Shalev R.S. Speed of performance of children with developmental right hemisphere syndrome and with attention-deficit hyperactivity dis­order // J Child Neurol. - 2003. - V. 18. - P. 264-268.
     
369. 
     Landau Y.E., Gross-Tsur V., Auerbach J.G. et al. Attention-deficit hyperactivity disorder and developmental right-hemisphere syndrome: congruence and incongruence of cognitive and behavioral aspects of attention // J Child Neurol. - 1999. - V. 14 - P. 299-303.
     
370. 
     Lane R.D., Chua P.M., Dolan R.J. Common effects of emotional valence, arousal and atten­tion on neural activation during visual processing in pictures // Neuropsychologia. - 1999. - V 37. - P. 989-997.
     
371. 
     Lapierre D., Braun C.M.J., Hodgings S. Ventral frontal deficits in psychopathy: neuropsycho­logical test findings // Neuropsychologia. - 1995. - V. 33. - P. 139-151.
     
372. 
     Lapin I.P. Structure-activity relationships in kynurenine, diazepam and some putative endogenous, ligands of the benzodiazepine receptors//Neurosci. A. Biobehav. Rev. 1983.-Vol.7.-P.107-118.
     
373. 
     Lau M.A., Pihl R.O., Peterson J.B. Provocation, acute alcohol intoxication, cognitive per­formance, and aggression // J Abnorm Psychol. - 1995. - V.104. - P. 150-155.
     
374. 
     Lawson J.A., Cook M.J., Vogrin S. et al. Clinical, EEG, and quantitative MRI differences in pediatric frontal and temporal lobe epilepsy // Neurology. - 2002. - V.58 - P. 723-729.
     
375. 
     LeDoux J.E. Emotions: clues from the brain. [Review] // Annu Rev Psychol. - 1995. - V. 46. - P. 209-235.
     
376. 
     Lee S.J. Nonconvulsive status epilepticus // Arch Neurol. - 1985. - V. 42. - P. 778-781.
     
377. 
     Leiderman D.B., Balish M., Bromfield E.B., Theodore W.JJ. Effect of valproate on human cerebral glucose metabolism // Epilepsia. - 1991. - V.32 - P. 417-422.
     
378. 
     Leiz S., Van-Stulpnagel C, Orden D. Levetiracetam as add-on therapy in idiopathic focal epilepsies // Epilepsia. - 2005. - V.46, Suppl. 6. - P. 103.
     
379. 
     Lenz F.A., Rios M., Zirh A. et al. Lesser painful stimuli evoke potentials recorded over the human anterior cingulate gyrus // The Journal of Neurophysiology. - 1998. - V. 79. - P. 2231-2234.
     
380. 
     Lethel V., ChabrolB., LivetM.O., ManciniJ. Lamotrigine therapy in children. Retrospective study of 32 children // Arch Pediatr. - 2000. - V. 7. - P. 234-242.
     
381. 
     Levin В., Duchowny M. Childhood obsessive-compulsive disorder and cingulate epilepsy // Biol Psychiatry. - 1991. - V. 30. - P. 1049-1055.
     
382. 
     Levine D.N., Finklestein S. Delayed psychosis after right temporo-parietal stroke and seizures or trauma: relation to epilepsy // Neurology. - 1982. - V. 32. - P. 267-273.
     
383. 
     Lewine J.D., Andrews R., Chez M. et al. Magnetoencephalographic Patterns of Epileptiform Activity in Children With Regressive Autism Spectrum Disorders // Pediatrics. - 1999. - Vol. 104. - P. 405-418.
     
384. 
     Lewine Jeffrey D., Davis John Т., Funke Michael et al. A Long Letter and an Even Longer Reply About Autism Magnetoencephalography and Electroencephalography // Pediatrics. - 2001. - V.107. - P. 1232-1235.
     
385. 
     Libenson Mark H., Caravale Barbara, Prasad Asuri N. Clinical correlations of occipital epileptiform discharges in children // Neurology. - 1999. - V.53. - P. 265.
     
386. 
     Licht R., Bakker D.J., Kok A. Bouma A. The development of lateral event-related potentials (ERPs) related to word naming: a four year longitudinal study // Neuropsychologia. - 1988. - V 26. - P. 327-340.
     
387. 
     Liechti M.E., Baumann C. Acute psychological effects of methylenedioxymethamphetamine are attenuated by the serotonin uptake inhibitor citalopram //Neuropsychopharmacology.-2000.-Vol.22, N5.-P.513-521.
     
388. 
     Liegeois F. de Schonen S. Picture naming in young children: a developmental study on inter-hemispheric collaboration // Brain Cogn. - 2002. - V. 49. - P. 123-137.
     
389. 
     Lindsay J., Ounstead C, Richards P. Long term outcome in children with temporal lobe seizures, III: psychiatric aspects in childhood and adult life // Dev Med Child Neurol. -1979.-V. 21.-P. 630-636.
     
390. 
     Locascio J.J., Malone R.P., Small A.M. et al. Factors related to haloperidol response and dyskinesias in autistic children // Psychopharmacol Bull. - 1991. - V. 27. - P.119-126.
     
391. 
     LockardJ.S. A primate model of clinical epilepsy. Mechanisms of action through quantifica­tion of therapeutic effects. In: Lockhard J.S. Ward A.A. (eds): Epilepsy: A window to Brain Mechanisms. New York, Rawen Press, 1980.
     
392. 
     LockardJ.S. Social primate model of epilepsy. In: Lockhard J.S. Ward A.A. (eds): Epilepsy: A window to Brain Mechanisms. New York, Rawen Press, 1980a.
     
393. 
     Logsdail S.J., Toone B.K. Postictal psychosis: a clinical and phenomenological description // Br J Psychiatry. - 1988. - V. 152. - P. 246-252.
     
394. 
     Loisau P., Panayiotopoulos Ch.P, Hirsh E. Childhood absence epilepy and related syndromes // Epileptic syndromes in Infancy, Childhood and Adolescence (3rd edn). J.Roger, M.Barbau, Ch.Dravet, P.Genton, C.A.Tassinari & RWolf. 2002 John Libbey & Co Ltd, p. 203-227.
     
395. 
     Loiseau P., Beaussart M. Hereditary factors in partial epilepsy // Epilepsia. - 1969. - V. 10. - P. 23-31.
     
396. 
     Loiseau P., Fame J. Une forme particuliere d'epilepsie de la seconde enfance // J. med. Bordeaux. - 1961. - V. 138. - P. 381-289.
     
397. 
     Loiseau P., Pestre M., Dartigues J.F. et al. Long-term prognosis in two forms of childhood epilepsy: typical absence seizures and epilepsy with rolandic (centrotemporal) EEG foci // Ann Neurol. - 1983. - V. 13. - P. 642-648.
     
398. 
     Loiseau P.,Cohadon F., Mortureux Y. A propos d'une forme singuliere d'epilepsie de l'enfant // Rev. Neurol. (Paris). - 1967. - V. 116. - P. 244-248.
     
399. 
     Lombroso С. Т. Silvian seizures and mid-temporal spike foci in children // Arch. Neurol. - 1967. - V. 17. - P. 52-59.
     
400. 
     Loring David W., KimfordJ. Meador. Cognitive side effects of antiepileptic drugs in children // Neurology. - 2004. - V. 62. - P. 872-877.
     
401. 
     Loscher W. Potschka Heidrun. Blood-Brain Barrier Active Efflux Transporters: ATP-Binding Cassette Gene Family // NeuroRx. - 2005. - V 2. - P. 86-98.
     
402. 
     Loscher W., Potschka H. Role of multidrug transporters in pharmacoresistance to antiepilep­tic drugs // Journal of pharmacology and experimental therapeutics. - 2002, - V. 301. - P. 7-14.
     
403. 
     Lott I. Т., Coulombe Т., Di Paolo R. V. et al. Vitamin B6-dependent seizures: pathology and chemical findings in brain // Neurology. - 1978. - V. - P. 47-54.
     
404. 
     Lowey A., McKellar S. Serotoninergic projections from the ventral medulla to the intermediolateral cell column in the rat//Brain Res.- 1991. -Vol.211.- N1.-P.146-152.
     
405. 
     Lucey J. V., Costa D.C., Adshead G et al. Brain blood flow in anxiety disorders. OCD, panic disorder with agoraphobia, and post-traumatic stress disorder on 99mTcHMPAO single pho­ton emission tomography (SPET) //The British Journal of Psychiatry. - 1997. - V. 171. - P. 346-350.
     
406. 
     Lucey J. V., Costa D.C., Blanes T. et al. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions // The British Journal of Psychiatry. - 1995. - V.167. - P. 629-634.
     
407. 
     Luthringer R., D’Arbigny K., Macher J.P. Ginkgo biloba extract (EGb 761), EEG and event–related potentials mapping profile /Y. Christen, Y. Courtois, M.T. Droy–Lefaix (eds). Effects of Ginkgo biloba extract (EGb 761) on aging and age–related di orders //Advances in Ginkgo biloba Extract Research.–1995. –Vol.4.-P.107–118.
     
408. 
     Lynch Berkley A., Lambeng Nathalie, Nocka Karl et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam // PNAS. - 2004. - V.101. - P. 9861-9866.
     
409. 
     Malloy P., Bihrle A., Duffy J. The orbitomedial frontal syndrome // Arch Clin Neuropsychol. - 1993. - V. 8. - P. 185-201.
     
410. 
     Manford M., Fish D.R., Shorvon S.D. An analysis of clinical seizure patterns and their localizing value in frontal and temporal lobe epilepsies //Brain.- 1996.- Vol.119.-P.-17-40.
     
411. 
     Mangano N.G. Epilepsies and time to diagnosis. Descriptive results of the Carole survey //Rev. Neurol.(Paris).- 2000.-Vol.156, №5.-P.481-490.
     
412. 
     Manganotti P., Miniussi C, Santorum E. et al. Influence of somatosensory input on paroxys­mal activity in benign rolandic epilepsy with 'extreme somatosensory evoked potentials' // Brain. - 1998. - V.121. - P. 647-658.
     
413. 
     Marrosu F., Brundu A., Rachele M.G., Marrosu G. Epileptic aphasia as dynamic disturbance. A case report // Acta Neurol (Napoli). - 1983. - V. 5. - P. 43-46.
     
414. 
     Marshall J.E., SyedG.M.B., Fenwick P.B.C., Lishman W.A. A pilot study of schizophrenia­like psychosis in epilepsy using single-photon emission computerised tomography // Br J Psychiatry. - 1993. - V. 163. - P. 32-36.
     
415. 
     Marston D., Besag F, Binnie CD., Fowler M. Effects of transitory cognitive impairment on psychosocial functioning of children with epilepsy: a therapeutic trial // Dev Med Child Neurol. - 1993. - V 35. - P. 574-581.
     
416. 
     Massa R., de Saintandash A., Carcangiu R. et al. EEG criteria predictive of complicated evo­lution in idiopathic rolandic epilepsy // Neurology 2001. - V. 57. - P. 1071-1079.
     
417. 
     Matejcek M. Vigilance and the EEG: psychological, phisiological and pharmacological aspects /W.M. Hermann (ed). Electroencefalography in Drug Research.- Fisher, Shtuttgart, –1982. –P.405–508.
     
418. 
     MatricardiM., BrinciottiM., PaolellaA., PorroG., Benedetti P. Neuropsychological correlates of subclinical paroxysmal EEG activity in children with epilepsy: quantitative aspects // Functional Neurol. - 1989. - V. 4. - P. 241-246.
     
419. 
     Mattes A., Schneble H. Epilepsien. Diagnostik und Terapie fur Klinik und Praxis, Tieme \ferlag Stuttgart New York, 1992.
     
420. 
     Mazurkiewicz-Beldzinska Maria, Olszewska Anna. Wplyw karbamazepiny, fenytoiny i okskar-bazepiny na funkcje poznawcze u dzieci chorych na padaczke // Epileptologia. - 2000. - V.8. - P. 1-8.
     
421. 
     McDanal C.E, Bolman W.M. Delayed idiosyncratic psychosis with diphenylhydantoin // JAMA. - 1975. - V. 321. - P. 1063.
     
422. 
     McEachin J.J., Smith Т., Lovaas O.I. Long-term outcome for children with autism who received early intensive behavioral treatment // American Journal on Mental Retardation. - 1993. - V. 97. - P. 359 -372.
     
423. 
     Me Eva, Exner Cornelia, Thielen Karsten et al. Obsessive-Compulsive Disorder and Ventromedial Frontal Lesions: Clinical and Neuropsychological Findings // Am. J. Psychiatry. - 1998. - V. 155. - P. 255-263.
     
424. 
     Mechanism of delayed increases in kynurenine pathway metabolism in damagen brain regions following transient cerebral ischemia/K. Saito, T.S. Nowak, S.P. Markey, M.P. Heyes// J. Neurochem.-1993.- Vol.60, N1.-P.180-192.
     
425. 
     Medford Nick, Sierra Mauricio, Baker Dawn, David Anthony S. Understanding and treating depersonalisation disorder//Advan. Psychiatr. Treat. - 2005. - V 11. - P. 92-100.
     
426. 
     Mednik S.A., Volavka J., Gabrielli W.F. et al. EEG as a predictor of antisocial behavior // Criminology. - 1982. - V.19. - P. 219-231.
     
427. 
     Meldrum B.S. Pathophysiology of chronic epilepsy. In.: Trimble M.R. (ed.). Chronic epilep­sy: its prognosis and management. John Wiley a. Sons Inc., NY, 1989. P. 1-12.
     
428. 
     Menkes J. H, Sankar R. Paroxysmal disorders. In: «Child neurology» (Menkes J. H., Sarnat H. В., eds.). 6-th ed. Philadelphia-Baltimore: Lippincott Williams and Wilkins, 2000, p. 919-1026.
     
429. 
     Mereu G, Fa M., Santoni F. et al. Levetiracetam decreases spontaneous spiking activity and increases EEG gamma frequencies in DBA2J mice: role of GABA receptors // Epilepsia. - 2005. - V. 46. - Suppl. 6. - P. 268.
     
430. 
     Miller B.L., Darby A., Benson D.F., CummingsJ.L., Miller M.H. Aggressive, and socially dis­ruptive and antisocial behaviour associated with fronto-temporal dementia // Br J Psychiatry. - 1997. - V. 170. - P. 150-154.
     
431. 
     Miller J. W., Yanagihara Т., Petersen R.C., Klass D. W. Transient global amnesia and epilepsy: electroencephalographic distinction // Arch Neurol. - 1987. - V.44. - P.629-633.
     
432. 
     Millichap J. G. Behavior Problems Antedating Clinical Epilepsy // AAP Grand Rounds. - 2001. - V. 5. - P. 42 - 43.
     
433. 
     Mindus P., Rasmussen S.A., Lindquist С Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function // J. Neuropsychiatry. Clin. Neurosci. - 1994. - V. 6. - P. 467 - 477.
     
434. 
     Minshew N.J., Goldstein G., Dombrowski S.M. et al. A preliminary 3IP MRS study of autism: evidence for undersynthesis and increased degradation of brain membranes // Biological Psychiatry. - 1993. - V. 33. - P. 762 -773.
     
435. 
     MirskyA.F., Duncan C.C., Levav M.L. Neuropsychological and psychophysiolgical aspects of absence epilepsy. In: Duncan J.S., Panayiotopoulos C.P. (eds) // Typical absence and relat­ed epileptic syndromes. Edinburgh: Churchill Livingstone. P. 112-121.
     
436. 
     Miyauchi Т., Nomura Y, Ohno S., Kishimoto H., Matsushita M. Positron emission tomogra­phy in three cases of Lennox-Gastaut syndrome // Japanese Journal of Psychiatry and Neurology. - 1988. - V.42. - P. 795-804.
     
437. 
     Mochizuki H., Saito H. Mesial frontal lobe syndromes: correlations between neurological deficits and radiological localizations // Tohoku J Exp Med. - 1990. - V. 161, Suppl. - P. 231-239.
     
438. 
     Modulation of guinolinic and kynurenic acid content in the rat brain: effects of endotoxins and nicotinylalanine/F. Moroni, P. Russi, M.A. Gallo-Mezo, G. Moneti, R. Pellicciari//J.Neurochem.-1991.-Vol.57, N5.-P.1630-1645.
     
439. 
     Montero P.J. Fluoxetine and convulsive crisis//Med Clin.(Barc.).-2000.- Vol.114, N20.-P.790-793.
     
440. 
     Montero P.J. Fluoxetine and convulsive crisis //Med. Clin. (Barc.).-2000.- Vol.114, №20.-P.790-793.
     
441. 
     Moon Нее Han, Chang Kee-Hyun, Kwon Jun Soo. Volumetric Investigation of the Frontal-Subcortical Circuitry in Patients With Obsessive-Compulsive // Disorder J. Neuropsychiatry. Clin. Neurosci. - 2004. - V. 16. - P. 342 - 349.
     
442. 
     Moroni F. Comparison of the neurochemical and behavioral effects resulting from the inhibition of kynurenine hydroxylase and/or kynureninase//J.Neurochem.- 1995.-Vol.65, N3.-P.1176-1183.
     
443. 
     Morrell F, Whisler W., Bleck T.P. Multiple subpial transection: a new approach to the surgical treatment of focal epilepsy [see comments] //J Neurosurg. - 1989. - V. 70. - P. 231-239.
     
444. 
     Morrell F, Whisler W., Smith M.C. et al. Landau-Kleffner syndrome: treatment with subpial intracortical transection // Brain. - 1995. - V. 118. - P. 1529-1546.
     
445. 
     Morrell F. Electrophysiology of ESES and Landau-Kleffner syndrome // Beaumanoir A., Bureau Т., Mira L., Tassinari С (eds). Continuous spikes and waves during slow sleep. Electrical status epilepticus during slow sleep. London: John Libbey. - 1995. - P. 77-90.
     
446. 
     Morris Т., Jafari Neda, Rice Ann С et al. Persistent increased DNA-binding and expression of serum response factor occur with epilepsy-associated long-term plasticity changes // Journal of Neuroscience. - 1999. - V. 19. - P. 8234-8243.
     
447. 
     Mouridsen S.E. The Landau-Kleffner Syndrome, a review // European Child & Adolescent Psychiatry. - 1995. - V. 4. - P. 223-228.
     
448. 
     Muhle Rebecca, Trentacoste Stephanie V, Rapin Isabelle. The Genetics of Autism // Pediatrics. - 2004. - V. 113. - P. 472-486.
     
449. 
     Mula M., SanderJ.W., Trimble M.R. The role of hippocampal sclerosis in drug related psy-chopathology of epilepsy // Epilepsia. 2002 - V.44, Suppl. 8. - P. 53.
     
450. 
     Mula M., Trimble M.R., Lhatoo S.D., Sunder J. W. Topitamate and psychiatric adverse events in patients with epilepsy // Epilepsia. - 2003. - V. 44. - P. 659-663.
     
451. 
     Muller-Oerlinghausen В., Retzow A., Henn F.A., et al, for the European Valproate Mania Study Group. Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicen-ter study // J Clin Psychopharmacol. - 2000. - V.20. - P. 195-203.
     
452. 
     Nabbout R., Dulac 0. Epileptic encephalopathies: a brief overview // J Clin Neurophysiol. - 2003. - V. 20. - P. 393-397.
     
453. 
     Nabbout R., Soufflet C, Plouin P., Dulac O. Pyridoxine dependent epilepsy: a suggestive elec-troclinical // Arch Dis Child Fetal Neonatal Ed. - 1999. - V.81. - P. F125-F129.
     
454. 
     Nanda A.S., Westenskow P., Charlier С et al. KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum// Brain. - 2003. - V. 126. - P. 2726-2737.
     
455. 
     Nass R., Devinsky 0. Autistic regression with rolandic spikes // Neuropsychiatry Neuropsychol Behav Neurol. - 1999. - V. 12. - 193-197.
     
456. 
     Nass R., Gross A., Devinsky O. Autism and autistic epileptiform regression with occipital spikes// Dev Med Child Neurol. - 1998. - V.40. - P. 453-458.
     
457. 
     Nass R., Gross A., WisoffJ., Devinsky O. Outcome of multiple subpial transection for autistic epileptiform regression // Pediat Neurol. - 1999. - V. 21. - P. 464-470.
     
458. 
     Nayrac P., Beaussart M. Les points-ondes prerolandiques: expression EEG tres particulier. Etude electro-clinique de 21 cas // Rev. Neurol. (Paris). - 1958. - V.99. - P. 201-206.
     
459. 
     Neppe V.M. Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities // J Clin Psychiatry. - 1983. - V. 44. - P. 326-331.
     
460. 
     Neppe V.M., Tucker G.J. Modern perspectives on epilepsy in relation to psychiatry: behav­ioral disturbances of epilepsy // Hosp Community Psychiatry. - 1988. - V. 39. - P. 389-396.
     
461. 
     Neubauer B.A., Sephani U., Doose H. et al. The genetic of focal epilepsy and related condi­tions: multifactorial inheritance with a major gene effect // Genetic of focal epilepsies: Clinical aspects and molecular biology. S.F.Bercovic, PGenton, E. Hirsch and F. Picard. - 1999. - John Libbey & Company Ltd. - P. 57-66.
     
462. 
     Neurotrific (and/of neuritogenic) properties of the extract of Ginkgo biloba (Egb 761) as an evidence in vestibular compensation/M. Lacour, L. Ez–Zaher, J. Raymond, B. Tighilet/ Y. Cristen, J. Costentin, M. Lacour (eds). Effects of Ginkgo biloba ex racts on the cental nervous system//Advances in Ginkgo biloba extract research. –1992. –Vol.4.-P.37–56.
     
463. 
     Neville B.G. Boyd S.G. Selective epileptic gait disorder // J. Neurol. Neurosurg. Psychiatry. - 1995.-V. 58.-P. 371-373.
     
464. 
     Neville B.G., Harkness W.F., Cross J.H., Cass H.C, Burch V.C., Lees J.A., Taylor D.C Surgical treatment of severe autistic regression in childhood epilepsy // Pediatr Neurol. - 1997. - V. 16. - P. 137-140.
     
465. 
     Neville B.G.R. Reversible disability associated with epilepsy // Brain Dev. - 1999. - P. 82-85.
     
466. 
     Neville B.G.R., Besag F.M.C., Marsden CD. Exercise induced steroid dependent dystonia, ataxia, and alternating hemiplegia associated with epilepsy // J. Neurol. Neurosurg. Psychiatry. - 1998. - V. 65. - P. 241-244.
     
467. 
     Neville B.G.R., Spratt H.C, Birtwistle J. Early onset epileptic auditory and visual agnosia with spontaneous recovery associated with Tourette's syndrome // J. Neurol. Neurosurg. Psychiatry. - 2001. - V. 71. - P. 560-561.
     
468. 
     New Webster's Dictionary of the English Language. 158 000 Entries. College Edition // .Surjeet Publications, Foth Reprint, 1988.149. - P. 152-158.
     
469. 
     Niedermeyer E. Abnormal EEG patterns: epileptic and paroxysmal. In: Niedermeyer E., Da Silva L. eds. Electroencephalography: basic principles, clinical applications, and related fields. Baltimore: Williams and Wilkins, 1993.- Vol. 217-240.
     
470. 
     Niedermeyer E. Abnormal EEG patterns: epileptic and paroxysmal. In: Niedermeyer E, Da Silva L, eds. Electroencephalography: basic principles, clinical applications, and related fields. Baltimore: Williams and Wilkins, 1993. - V. 217-240.
     
471. 
     Niedermeyer E. Epileptic seizure disorders. In: Niedermeyer E, Da Silva L, eds. Electroencephalography: basic principles, clinical applications, and related fields. Baltimore: Williams and Wilkins, 1993. - V. 461-564.
     
472. 
     Niedermeyer E. Frontal lobe functions and dysfunctions // Clin Electroencephalogr. - 1998. - V. 29. - P. 79-90.
     
473. 
     Niedermeyer E. Primary (idiopathic) generalized epilepsy and underlying mechanisms // Clin Electroencephalogr. - 1996. - V. 27. - P. 1-21.
     
474. 
     Nishida Т., Kudo Т., Nakamura F. et al. Postictal mania associated with frontal lobe epilep­sy// Epilepsy Behav. - 2005. - V. 6. - P. 102-110.
     
475. 
     O'Connor S., Bauer L., Tasman A. et al. Reduced P3 amplitudes are associated with both a family history of alcoholism and antisocial personality disorder // Prog Neuropsychopharmacol Biol Psychiatry. - 1994. - V.18. - P. 1307-1321.
     
476. 
     Oishi M., Otsubo H., Kameyama S. etal. Ictal magnetoencephalographic discharges from ele­mentary visual hallucinations of status epilepticus // Journal of Neurology Neurosurgery and Psychiatry. - 2003. - V.74. - P. 525-527.
     
477. 
     Okubo , Matsuura M., Asai T. et al. Epileptiform EEG discharges in healthy children: prevalence, emotional and behavioral correlates, and genetic influences // Epilepsia. - 1994. - V. 35. - P.832-843.
     
478. 
     Okuyaz K., Gucuyener Aydin K., Serdaroglu A. Treatment of electrical status epilepticus dur­ing slow-wave sleep with high-dose corticosteroid // Pediatr Neurol. - 2005. - V. 32. - P. 64-67.
     
479. 
     On the mechanism of antithrombotic action of flavinoids/R.J. Grylewski, R. Korbut, J. Robak, J. Swies//Biochem Pharmacol. –1987. – Vol.36. –P.317–322.
     
480. 
     Ong Hian-Tat, Wyllie E. Benign childhood epilepsy with centrotemporal spikes: Is it always benign? //Neurology. - 2000. - V. 54. - P. 1182-1185.
     
481. 
     Onset of memory disorders: specific and combined contribution of memory–training programs and Ginkgo biloba (Egb 761) treatment/Y. Christen, Y. Courtois, M.T. Droy–Lefaix (eds). Effects of Ginkgo biloba extract (EGb 761) on aging and age–related disorders//Advances in Ginkgo biloba Extract Research. –1995. –Vol.4.-P.119–130.
     
482. 
     O'Regan M.E., Brown J.K., Goodwin G.M., Clarke M. Epileptic aphasia: a consequence of regional hypometabolic encephalopathy? // Dev Med Child Neurol. - 1998. - V. 40. - P. 508-516.
     
483. 
     Otsubo H., Chitoku S., Ochi A. et al. Malignant rolandic-sylvian epilepsy in children. Diagnosis, treatment, and outcomes // Neurology. - 2001. - V.57. - P. 590-596.
     
484. 
     Oxygen–centered free radicals and their interaction with Egb 761 or CP 202 /M. Gardes–Albert, C. Ferradini, A. Sekaki, M.T. Droy–Lefaix, Y.Christen (eds). Ginkgo biloba extract as free radical scavenger //Advances in Ginkgo biloba Extract Research. –1993. –Vol.2.–P.1–12.
     
485. 
     Pan A., Gupta A., Wyllie E. et al. Benign focal epileptiform discharges of childhood and hip­pocampal sclerosis // Epilepsia. - 2004. - V 45. - P. 284-288.
     
486. 
     Panayiotopoulos C.P. Extraoccipital benign childhood partial seizures with ictal vomiting and excellent prognosis //J Neurol Neurosurg Psychiatry. - 1999. - V.66. - P. 82-85.
     
487. 
     Panayiotopoulos C.P. Idiopathic childhood occipital epilepsies // Epileptic syndromes in Infancy, Childhood and Adolescence (3rd edn). J.Roger, M.Barbau, Ch.Dravet, P.Genton, C.A.Tassinari & P.Wolf. 2002 John Libbey & Co Ltd. - P. 203-227.
     
488. 
     Panayiotopoulos C.P. Panayiotopoulos syndrome: a common and benign childhood epileptic syndrome. London: John Libbey, 2002.
     
489. 
     Panayiotopulos C.P. Benign childhood partial epilepsies: benign childhood seizure suscepti­bility syndromes // J. Neurol. Neurosur. Psychiatry. - 1993. - V. 56. - P. 2-5.
     
490. 
     Panayiotopulos C.P. Benign childhood partial seizures and related epileptic syndromes. John Libbey & Company Ltd. 1999.
     
491. 
     Panayiotopulos C.P. Letter to the editor// Epilepsia. - 1999. - V.50. - P. 1320-1324.
     
492. 
     Papavasiliou A., Mattheou D., Bazigou H., Kotsalis C, Paraskevoulakos E. Written language skills in children with benign childhood epilepsy with centrotemporal spikes // Epilepsy & Behavior. - 2005. - V 6. - P. 50-58.
     
493. 
     Paquier P.P., Van Dongen H.R., Loonen C.B. The Landau-Kleffher syndrome or «acquired aphasia with convulsive disorder»: long-term follow-up of 6 children and a review of the recent literature // Arch Neurol 1992. - V.49. - P. 354-359.
     
494. 
     Paradise S., Johnson D.L., Andreasen N.C. et al. Cerebral blood flow changes associated with attribution of emotional valence to pleasant, unpleasant, and neutral visual stimuli in a PET study of normal subjects // Am J Psychiatry. - 1999. - V. 156. - P. 1618-1629.
     
495. 
     Pardo J.V., Pardo P.J., Raichle M.E. Neural correlates of self-induced dysphoria // Am J Psychiatry. - 1993. - V. 150. - P. 713-719.
     
496. 
     Parent Jack M., Yu Timothy W., Leibowitz Rebecca T. et al. Dentate granule cell neurogene­sis is increased by seizures and contributes to aberrant network reorganization in the adult rat hippocampus // J. Neuroscience. - 1997. - V. 17. - P. 3727-3738.
     
497. 
     Parkinson G.M. High incidence of language disorder in children with focal epilepsies // Dev. Med. Child. Neurol. - 2002. - V. 44. - P. 533-537.
     
498. 
     Parmeggani L., Guerrini R. Idiopatic partial epilepsy: electroclinical demonstration of a pro­longed seizure with sequential rolandic and occipital involvement. Seizure spraed due to regional susceptebility? // Epileptic disorders. - 1999. - V. 1. - P. 35-40.
     
499. 
     Parry-Fielder В., Nolan T.M., Collins K.J., Stojcevski Z. Developmental language disorders and epilepsy // J. Paediatr. Child Hlth. - 1997. -Vol. 33. - P. 277-280.
     
500. 
     Patill A.A., Andrews R.V. Surgical treatment of autistic epileptiform regression // J Epilepsy. - 1998. - V. 11. - P. 368-373.
     
501. 
     Patry G., Lyagoubi S., Tassinari C.A. Subclinical electrical status epilepticus induced by sleep in children // Arch Neurol 1971. - V.24. - P. 242-252.
     
502. 
     Penfield W. Temporal lobe epilepsy //Brit. J. Surg.-1954.-Vol. 41 (168).-P.337-343.
     
503. 
     Penfield W.Temporal lobe epilepsy //Brit.J.Surg.-1954.-V.41 (168).-P.337-343.
     
504. 
     Perez E.R., Davidoff V. Sign language in childhood epileptic aphasia (Landau-Kleffher syn­drome) // Dev Med Child Neurol. - 2001. - V. 43. - P. 739-744.
     
505. 
     Perez E.R., DavidoffV., Despland PA, Deonna T. Mental and behavioural deterioration of children with epilepsy and CSWS: acquired epileptic frontal syndrome // Developmental Medicine & Child Neurology. - 1993. - Vol. 35. - P. 661-674.
     
506. 
     Perez M.M., Trimble M.R., Murray N.M.F., Reider I. Epileptic psychosis: an evaluation of PSE profiles // Br J Psychiatry 1985. - V. 146. - P. 155-163.
     
507. 
     Perminder Sachdev. Schizophrenia-Like Psychosis and Epilepsy: The Status of the Association // Am J Psychiatry. - 1998. - V. 155. - P. 325-336.
     
508. 
     Persinger M.A. Subjective improvement following treatment with carbamazepine (Tegretol) for a subpopulation of patients with traumatic brain injuries // Percept Mot Skills. - 2000. - V. 90. - P. 37-40.
     
509. 
     Perucca E. Management of refractory idipathic epilepsies // Epilepsia. - 2001. - V. 42. - Supplement 3. - P. 31-35
     
510. 
     Peterson B.S. Neuroimaging in child and adolescent neuropsychiatric disorders // J Am Acad Child Adolesc Psychiatry. - 1995. - V. 34. - P. 1560-1576.
     
511. 
     Picard A., Heraut F.C, Bouskaoui M., et al. Sleep EEG and developmental dysphasia // Developmental Medicine and Child Neurology. - 1998. - V. 40. - P. 595 -599.
     
512. 
     Picard F., Baulac S., Kahane P., Hirsch E. et al. Dominant partial epilepsies. A clinical, elec­trophysiological and genetic study of 19 European families // Brain. - 2000. - V. 123. - P. 1247-1262.
     
513. 
     Pidoux B., Bastein C., Niddam S. Clinical and quantative EEG double–blind study of GBE//J. Cerebral Blood Flow Metabolism. –1983. –Vol.3. –P.5556–5557.
     
514. 
     Pietrini P., Guazzelli M., Basso G. et al. Neural correlates of imaginal aggressive behavior assessed by positron emission tomography in healthy subjects // Am J Psychiatry 2000. - V. 157.-P. 1772-1781.
     
515. 
     Plesner A.M., Munk-Andersen E., Luhdorf K. Epileptic aphasia and dysphoria interpreted as endogenous depression // Acta Neurol Scand. - 1987. - V. 76. - P. 215-218.
     
516. 
     Plioplys A. Autism: electroencephalogram abnormalities and clinical improvement with val­proic acid // Archives of Pediatrics and Adolescent Medicine. - 1994. -Vol. - 148. - P. 220-222.
     
517. 
     Pollock D.C Models for understanding the antagonism between seizures and psychosis // Prog Neuropsychopharmacol Biol Psychiatry. - 1987. - V. 11. - P. 483-504.
     
518. 
     Pontius Anneliese A. Homicides with Partial Limbic Seizures: Is Chemical Seizure Kindling the Culprit? // Int J Offender Ther Comp Criminol. - 2001. - V. 45. - P. 515-527.
     
519. 
     Powell E.M., Campbell D.B., Stanwood G.D. Genetic Disruption of Cortical Interneuron Development Causes Region – and GABA Cell Type-Specific Deficits, Epilepsy, and Behavioral Dysfunction //J. Neurosci., 2003.- Vol. 23.- 622-631.
     
520. 
     Powell Elizabeth M., Campbell Daniel В., Stanwood Gregg D. et al. Genetic Disruption of Cortical Interneuron Development Causes Region - and GABA Cell Type-Specific Deficits, Epilepsy, and Behavioral Dysfunction // J. Neurosci. - Jan 2003. - V. 23. - 622-631.
     
521. 
     Praline J., Hommet C, Bartez C. et al. Outcome at adulthood of the continuous spike-waves in slow sleep and Landau-Kleffher syndromes // Epilepsia. - 2003. - V. 44. - P. 1434-1440.
     
522. 
     Prats J.M., Graraizar C, Garcia-Nieto M.L., Madoz P. Antiepileptic drugs and atypical evo­lution of idiopathic partial epilepsy // Pediatr. Neurol. - 1998. - V. 18. - P. 402-406.
     
523. 
     Pressler R., Robinson R.O., Wilson G.A., Binnie CD. Treatment of interictal EEG discharges improves behaviour in children with epilepsy // Epilepsia. - 2002. -Vol. 43, Suppl. 8. - P. 44
     
524. 
     Pressler, R.O., Robinson R.O., Wilson G.A., Binnie CD. Treatment of interictal epileptiform discharges can improve behavior in children with behavioral problems and epilepsy // J Pediatr. - 2005. - V. 146. - P. 112-117.
     
525. 
     Prevett M.C., Duncan J.S. Functional imaging studies in humans. In: Duncan JS, Panayiotopoulos CP, et al, eds. Typical absences and related epileptic syndromes. London: Churchill Communications, 1995. - V. 83-91.
     
526. 
     Primavera A., Bo G-P., Venturi S. Aphasic status epilepticus // Eur Neurol. - 1988. - V. 28. - P. 255-257.
     
527. 
     Proposed diagnostic scheme for people with epileptic seizures and with epilepsy. Summarized by Charlotte Dravet Member of the ILAE Task Force on Classification and Terminology // Epileptic syndromes in Infancy, Childhood and Adolescence (3rd edn). J.Roger, M.Barbau, Ch.Dravet, P.Genton, CATassinari & P.Wolf. 2002 John Libbey & Co Ltd, p. 535-536.
     
528. 
     Protective effect of Ginkgo biloba extract (Egb 761) against the lipid peroxidation of low density lipoproteins initiated by .OH and .02 free radicals / M. Gardes–Albert, A. Khalil, A. Fortun, Y. Christen, Y. Courtois, M.T. Droy–Lefaix (eds). Effects of Ginkgo biloba extract (EGb 761) on aging and age– related disorders //Advances in Ginkgo biloba Extract Research. –Vol.4. –1995. –P.49–64.
     
529. 
     Pujol Jesus, Soriano-Mas Carles, Alonso Pino et al. Mapping Structural Brain Alterations in Obsessive-Compulsive Disorder//Arch Gen Psychiatry. - 2004. - V. 61. - P. 720-730.
     
530. 
     Racy M.A, Osbom B.A V., Molinari G.F. Epileptic aphasia. First onset of prolonged mono-symptomatic status epilepticus in adults //Arch Neurol. - 1980. - V 37. - P. 419-422.
     
531. 
     Raine A, Lencz Т., Bihrle S., LaCasse L., Colletti P. Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder // Arch Gen Psychiatry. - 2000.-V. 57.-P. 119-127.
     
532. 
     Raine A., Buchsbaum M.S., Stanley J, Lottenberg S., Abel L., Stoddard J. Selective reduc­tions in prefrontal glucose metabolism in murderers // Biol Psychiatry. - 1994. - V. 36. - P. 365-373.
     
533. 
     Raine A., Stoddard J., Bihrle S., Buchsbaum M. Prefrontal glucose deficits in murderers lack­ing psychosocial deprivation // Neuropsychiatry Neuropsychol Behav Neurol. - 1998. - V 11.-P. 1-7.
     
534. 
     Ramamurthi B. Stereotactic operation in behaviour disorders. Amygdalotomy and hypothal-amotomy // Acta Neurochir Suppl (Wien). - 1988. - V. 44. - P. 152-157.
     
535. 
     Ramelli G.P., Donati F, Kaufmann F, Vassella F. Motor and cognitive profile during success­ful treatment in a case of continuous spike-waves during sleep (CSWS) // Epilepsia. - 1998. - V. 39. Suppliment 2. - P. 54.
     
536. 
     Rauch S.L., Jenike M.A., Alpert N.M. et al. A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry. - 1995. - V. 52. - P. 20-28.
     
537. 
     Rauch S.L., Jenike M.A., Alpert N.M. et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography // Arch Gen Psychiatry. - 1994. - V. 51. P. 62-70.
     
538. 
     Razdan S, KoulR.L. Epileptic aphasia. - Neurology. - 1987. - V. 37. - P. 1571.
     
539. 
     Reduction of platelet serotonin content in depressed patients treated with either paroxetine or desipramine/M.A. Javors, J.P. Houston, J.L. Tekell, S.K. Brannan//Int. J. Neuropsychopharmacol.- 2000.-Vol.3, N1.-P.123-131.
     
540. 
     Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells/D. Alberati-Giani, P. Ricciardi-Castagnoli, C. Kohler, A.M. Cesura//J. Neurochem. - 1996 -Vol.66,- N 3.-P.996-1004.
     
541. 
     Reiman E.M., Raichle M.E. et al. Focal brain abnormalities in panic disorder, a severe form of anxiety // Nature. - 1984. - V 310. - P. 683-685.
     
542. 
     Reith J., Benkelfat C, Shenvin A. et al. Elevated dopa decarboxylase activity in living brain of patients with psychosis // Proc Natl Acad Sci USA. - 1994. - V. 91. - P. 11651-11654.
     
543. 
     Remy S., Gabriel S., Urban B.W. et al. A novel mechanism underlying drug resistance in chronic epilepsy // Ann Neurol. - 2003. - V. 53. - P. 469-479.
     
544. 
     Reynolds E. Mechanisms of intractability. In: Epileptic seizures and syndromes. P. Wolf (ed.) - London: John Libbey, 1994 - P. 599-604.
     
545. 
     Riedel W.J., Klaassen T., Deutz N.E. Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation//Psychopharmacology.-1999.-Vol.141, N4.-P.345-345.
     
546. 
     Robertson M.M. Affect and mood in epilepsy: an overview with a focus on depression // Acta Neurol Scand. - 1992. - V 140. Suppl. - P. 127-132.
     
547. 
     Rocamora R., Schulze-Bonhage A. Levetiracetam reduces interictal activity frequency and duration in patients eith primary generalised epilepsy. // Epilepsia. - 2005. - V.46, Suppl. 6. - P. 102.
     
548. 
     Rolls E. T. Neurophysiology and functions of the primate amygdala. In: Aggleton J.P., editor. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction. New York: Wiley-Liss. -1992. - P. 143-165.
     
549. 
     Rosenbaum D.H., Siegel M., Ban W.B., Rowan A.J. Epileptic aphasia // Neurology. - 1986. - V. - P. 822-825.
     
550. 
     Ross E.D., Homan R. W., Ross B. Differential hemispheric lateralization of primary and social emotions // Neuropsychiatry, Neuropsychology and Behavioral Neurology. - 1994. - V.7. - P. 1-19.
     
551. 
     Rossi P.G., Parmeggiani A., Bach V., Santucci M., Visconti P. EEG features and epilepsy in patients with autism // Brain Dev. - 1995. - V. 17. - P. 169-174.
     
552. 
     Saavedra J. Distribution of serotonin and synthesizing enzymes in discrete areas of the brain//Federat. Pros.1997.-Vol.36, N8-P.2134-2141.
     
553. 
     Sadzot В., Debets R., Maquet P., Comar C, Franck G. PET studies of patients with partial epilepsy: visual interpretation vs semi-quantification/quantification // Acta Neurol Scand. - 1994. - V. 152. - P. 175-178.
     
554. 
     Sanchez-Carpintero R., Neville B.G. Attentional ability in children with epilepsy // Epilepsia. - 2003. - V. 44. - P. 1340-1349.
     
555. 
     Sander J.W.A.S., White H.S. Disease modification in epilepsy// Progress in neurology and psychiatry. 2001. Supplement. P. 1-12.
     
556. 
     Sato M. Long-lasting hypersensitivity to methamphetamine following amygdaloid kindling in cats: the relationship between limbic epilepsy and the psychotic state // Biol Psychiatry. - 1983. -V.18. - P. 525-536.
     
557. 
     Savard G., Andermann F, Olivier A., Remillard G.M. Postictal psychosis after partial complex seizures: a multiple case study // Epilepsia. - 1991. - V. 32. - P. 225-231.
     
558. 
     Schachter S.C., Galaburda A.M., Ransil B.J. Associations of dyslexia with epilepsy, handed­ness, and gender // Ann. N.Y. Acad. Sci. - Jun 1993. - V. 682. - P. 402-403.
     
559. 
     Scharfman Helen E., Goodman Jeffrey H., Sottas Anne L. Granule-like neurons at the hilar/САЗ border after status epilepticus and their synchrony with area CA3 pyramidal cells: functional implications of seizure-induced neurogenesis // Journal of Neuroscience. - 2000. - V. 20. - P. 6144-6158.
     
560. 
     Scheffer I.E. Autosomal dominant rolandic epilepsy with speech dyspraxia // Epileptic Disord. - 2000. - V. 2, Suppl. 1. - P. 19-22.
     
561. 
     Scheffer I.E. Familial partial epilepsy with variable foci. // Genetics of focal epilepsies: Clinical aspects and molecular biology. - 2000. - Berkovic S.F., Genton P., Picard F. (Eds). John Libbey & Company Ltd. - P. 103-108.
     
562. 
     Scheffer I.E., Jones L., Pozzebon M. Autosomal dominant rolandic epilepsy and speech dys­praxia: a new syndrome with anticipation // Ann Neurol. - 1995. - V. 8. - P. 633-642.
     
563. 
     Scheffer Ingrid E. Autosomal dominant rolandic epilepsy with speech dispraxia. In: Genetics of focal epilepsies: Clinical aspects and molecular biology. 2000. - Berkovic S.F., Genton P., Picard F. John Libbey & Company Ltd. - P. 109-114.
     
564. 
     Schindler K, Gast H., Bassetti C. et al. Hyperperfusion of anterior cingulate gyrus in a case of paroxysmal nocturnal dystonia // Neurology. - 2001. - V. 57. - P. 917-920.
     
565. 
     Schmitz B. Mood effects of antiepileptic drugs. In: Progress in epileptic disorders. V.l. Cognitive dysfunction in children with temporal lobe epilepsy // Arzimanoglou A. et al. (eds.). 2005, John Libbey Eurotext, Esher, Surrey, UK. - P. 233-250.
     
566. 
     Scholtes F.B., Renter W.O., Meinardi H. Non-convulsive status epilepticus: causes, treat­ment, and outcome in 65 patients // J Neurol Neurosurg Psychiatry. - 1996. - V. 61. - P. 93-95.
     
567. 
     Scott R.C., Neville B.G. Developmental perspectives on epilepsy // Curr Opin Neurol. - 1998.-V. 11.-P. 115-118.
     
568. 
     ScottD.F, SchwartzM.S. EEG features of depressive and schizophrenic states //The British Journal of Psychiatry. - 1975. - V. 126. - P. 408-413.
     
569. 
     Sechi G.P., Deiana G.A., Deriu M.G. et at. Non-fluent speech in patients with partial epilep­sy: beneficial effect of levetiracetam. // Epilepsia. - 2005. - V.46, Suppl. 6. - P. 104.
     
570. 
     Seidenwurm David, Pounds Thomas R., Globus Albert, Valk Peter E. Abnormal Temporal Lobe Metabolism in Violent Subjects: Correlationof Imaging and Neuropsychiatric Findings //AJNR Am J Neuroradiol. - 1997. - V. 18. - P. 625-631.
     
571. 
     Sem-Jacobsen C.W. Depth electrographic observations on psychotic patients: a system related to emotional behavior //Acta Psychiatr Scand.-1959.-V.34.-P.412-416.
     
572. 
     Semrud-Clikeman M., Wical B. Components of attention in children with complex partial seizures with and without ADHD // Epilepsia. - 1999. - V. 40. - P. 211-215.
     
573. 
     Shenvin I., Peron-Magnan P., Bancaud J, Bonis A., Talairach J. Prevalence of psychosis in epilepsy as a function of the laterality of the epileptogenic lesion // Arch, of neurol. - 1982. - V 39. - P. 621.
     
574. 
     Shorvon S. A semiological classification of status epilepticus // Epileptic disorders. - 2003.-V. 7.-P. 7-12.
     
575. 
     Shue K.L., Douglas V.I. Attention deficit hyperactivity disorder and the frontal lobe syn­drome // Brain Cogn. - 1992. - V. 20. - P. 104-124.
     
576. 
     ShuperA., Stahl В., Mimouni M. Transient opercular syndrome: a manifestation of uncon­trolled epileptic activity // Acta Neurol Scand. - 2000. - V 101. - P. 335-338.
     
577. 
     Simister Robert J, McLean Mary A., Barker Gareth J., Duncan John S. Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy // Neurology. - 2003. - V. 61. - P. 897-902.
     
578. 
     Sisodiya S.M. Mechanisms of antiepileptic drug resistance // Curr Opin Neurol. - 2003. - V 16. - P. 197-201.
     
579. 
     Sitzer G. Die zerebrovaskulare Insuffizienz //Kassenartz. –1997. – Bd.17-18. –S.2–12.
     
580. 
     Sitzoglu K.O.N., Papadopoulos КО. N, GrivasG.E.O. etal. Recovery ofexplicit memory after switching therapy using new generation antiepileptic drugs. // Epilepsia. - 2005. - V.46, Suppl. 6. - P. 107.
     
581. 
     Slater E., Beard A. W., Glithero E. The schizophrenia-like psychoses of epilepsy, i-v // Br J Psychiatry. - 1963. - V. 109. - P. 95-150.
     
582. 
     Smith D., Backer G., Davies G. et al. Outcome of add on treatment with lamotrigine in par­tial epilepsy. Epilepsia. - 1993. - V.34. - P. 312-322.
     
583. 
     Smith J.M.B., Kellaway P. Central (rolandic) foci in children: an analysis of 200 cases // Electroenceph. Clin, neurophysiol. - 1964. - V. 17. - P. 460.
     
584. 
     Smith M.C., Hoeppner T.J. Epileptic Encephalopathy of Late Childhood: Landau-Kleffner Syndrome and the Syndrome of Continuous Spikes and Waves During Slow-Wave Sleep // Journal of Clinical Neurophysiology. - 2003. - V. 20. - P. 462-472.
     
585. 
     Smith M.L., Elliott I..M., Snead O.C. Malignant rolandic-sylvian epilepsy in children Diagnosis, treatment, and outcomes // Neurology. - 2001. - V. 57. - P. 590-596.
     
586. 
     Sobel D.F., Otsubo H, Smith M.C. Magnetoencephalography in Children with Landau-Kleffner Syndrome and Acquired Epileptic Aphasia // American Journal of Neuroradiology. - 2000. - Vol. 21. - P. 301-307.
     
587. 
     Sokol Deborah K, Edwards-Brown Mary. Neuroimaging in Autistic Spectrum Disorder (ASD) // J Neuroimaging. - 2004. - V. 14. - P. 8-15.
     
588. 
     Soprano AM., Garcia E.F., Caraballo R., Fejerman N. Acquired epileptic aphasia, neuropsy­chologic follow-up of 12 patients //Pediatric Neurology. - 1994. - V.ll. - P. 230-235.
     
589. 
     Spinnewyn B., Blavet N., Qreieu K. Effect of Ginkgo biloba extract (Egb 761) on oxygen consumption by isolated cerebral mitochondria /Y. Christen, Y. Courtois, M.T. Droy–Lefaix (eds). Effects of Ginkgo biloba extract (EGb 761) on aging and age–related disorders//Advances in Ginkgo biloba Extract Research. –1999. – Vol.4.- P.17–22.
     
590. 
     Staden U., Isaacs E., BoydS.G. etal. Language dysfunction in children with Rolandic epilep­sy//Neuropediatrics. - 1998. - V. 29. - P. 242-248.
     
591. 
     State R.C., Altshuler L.L., FryeM.A. Mania and Attention Deficit Hyperactivity Disorder in a Prepubertal Child: Diagnostic and Treatment Challenges // Am. J. Psychiatry. - 2002. - V. 159. - P. 918-925.
     
592. 
     Staufenberg E.F., Brown S. W. Some issues in non-convulsive status epilepticus in children and adolescents with learning difficulties [see comments] // Seizure. - 1994. - V. 3 - P. 95-105.
     
593. 
     Stefanatos G.A., Graver W., Getter E. Case study: corticosteroid treatment of language regres­sion in pervasive developmental disorder//Journal of the Academy of Child and Adolescent Psychiatry. - 1995. -Vol. 34. - P. 1107-1111.
     
594. 
     Steriade M. Cellular substrates of brain rhythms. In: Niedermeyer E, Da Silva L. eds. Electroencephalography: basic principles, clinical applications, and related fields. Baltimore: Williams and Wilkins, 1993.- P. 27-62.
     
595. 
     Steriade M. Cellular substrates of brain rhythms. In: Niedermeyer E, Da Silva L, eds. Electroencephalography: basic principles, clinical applications, and related fields. Baltimore: Williams and Wilkins, 1993. - P. 27-62.
     
596. 
     Stevens J.R. Clozapine: the yin and yang of seizures and psychosis // Biol Psychiatry. - 1995. - V. 37. - P. 425-426.
     
597. 
     Stevens J.R. Epilepsy, Schizophrenia, and the Extended Amygdala // Ann. N.Y. Acad. Sci. - 1999. - V 877. - P. 548.
     
598. 
     Stevens J.R. Psychiatric consequences of temporal lobectomy for intractable seizures: a 20-30 year follow-up of 14 cases // Psychol Med. - 1990. - V. 20. - P. 529-545.
     
599. 
     Stone J.L., McDaniel K.D., Hughes J.R., Hermann B.P. Episodic dyscontrol disorder and paroxysmal EEG abnormalities: successful treatment with carbamazepine // Biol Psychiatry. - 1986. - V. 21. - P. 208-212.
     
600. 
     Stone Valerie £., Baron-Cohen Simon, Knight Robert T. Frontal Lobe Contributions to Theory of Mind // The Journal of Cognitive Neuroscience. - 1998. - V. 10. - P. 640-656.
     
601. 
     Studio clinico in doppio cieco del Tanakan nell”insufficienza cerebrale cronica /G. Dieli, V. LaMantia, M. Saetta, E. Constanzo//Lav Neuropsihiatr. –1981. –Vol.68. –P.3–15.
     
602. 
     Sutula Т., НеХ.Х., CavazosJ., Scott G. Synaptic reorganization in the hippocampus induced by abnormal functional activity//Science. - 1988. - V. 239. - P. 1147-1150.
     
603. 
     Swanberg M.M., Nasreddine Z.S., Mendez M.F., Cummings J.L. Chapter 6. Speech and lan­guage. // Textbook of clinical neurology / edited by] Christopher G. Goetz. - 2nd ed. - 2003. - P. 77-98.
     
604. 
     Swartz Conrad M., Bottum Kathleen M., Salazar Leonardo S. Jr. Suppression of Catatonia-Like Signs by Lorazepam in Nonconvulsive Status Epilepticus Without Seizure Termination // Am J Geriatr Psychiatry. - 2002. - V. 10. - P. 348-350.
     
605. 
     Swedo S.E., Schapiro M.B., Grady C.L. et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder Arch Gen Psychiatry. - 1989. - V 46. - P. 518-523.
     
606. 
     Swoboda K.J., Jenike M.A. Frontal abnormalities in a patient with obsessive-compulsive dis­order: the role of structural lesions in obsessive-compulsive behavior // Neurology. - 1995. _ V. - P. 2130-2134.
     
607. 
     Szeszko Philip R., MacMillan Shauna, McMeniman Marjorie et al. Brain Structural Abnormalities in Psychotropic Drug-Naive Pediatric Patients With Obsessive-Compulsive // Disorder Am. J. Psychiatry. - 2004. - V. 161. - P. 1049 - 1056.
     
608. 
     Szeszko Philip R., Robinson Delbert, Ahir Jose Ma.J. et al. Orbital Frontal and Amygdala \folume Reductions in Obsessive-compulsive Disorder // Arch Gen Psychiatry. - 1999. - V. 56. - P. 913-919.
     
609. 
     Takanori Yamagata, Momoi Mariko Y, Miyao Masutomo et al. Blink induced centrotempo-ral spikes in benign childhood epilepsy with centrotemporal spikes // J Neurol Neurosurg Psychiatry. - 1997. - V.63. - P. 528-530.
     
610. 
     Talwar D., Arora M.S., Sher P.K. EEG changes and seizure exacerbation in young children treated with carbamazepine // Epilepsia. - 1994. - V. 35. - P. 1154-1159.
     
611. 
     Tan M., Appleton R. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy // Archives of Disease in Childhood. - 2005. - V.90. - P. 57-59.
     
612. 
     Tanaka Naoaki, Kamada Kyousuke, Takeuchi Fumiya, Takeda Youji. Magnetoencephalographic Analysis of Secondary Bilateral Synchrony // J Neuroimaging. - 2005. - V. 15. P. 89-91.
     
613. 
     Taneii B. Epileptic phenomena underlying psychiatric disorders: schizophrenic disorder, affective and anxiety disorder // Epileptologia. - 2001. - V.9, Suppl. 1. - P. 18-19.
     
614. 
     Taylor D.C., Neville B.G., Cross J.H. Autistic spectrum disorders in childhood epilepsy sur­gery candidates // Eur Child Adolesc Psychiatry. - 1999. - V. 8. - P. 189-192.
     
615. 
     Taylor J. Selected writings of John Hughlings Jackson.- New York: Basic Books, 1958.-256 p.
     
616. 
     Taylor J.Selected writings of John Hughlings Jackson, Vol 1.- New York: Basic Books, 1958.-256 p.
     
617. 
     Tharpe AM., Olson B.J. Landau-Kleffher syndrome: acquired epileptic aphasia in children // Journal of the American Academy of Audiology. - 1994. - V. 5. - P. 146-150.
     
618. 
     The effect of acute tryptophan depletion and fenfluramine on guantitative EEG and mood in healthy male subjects/ V.J. Knott, A.L. Howson, M. Perugini, A.V. Ravindran//Amer. J. Clin. Nutr. – 2000.-Vol.74, N8.-P.1541-1548.
     
619. 
     The bovine protein alpha-lactalbumin increases the plasma ratio of tryptophan to the other large neutral amino asids, and in vulnerable subjects raises brain serotonin activity, reduces cortisol concentration and improves mood under stress /C.R. Markus, B. Olivier, J. Van Der-Gugten, M.S. Alles //Amer. J. Clin. Nutr.- 2000.-Vol.71, №6.-P.1536-1544.
     
620. 
     Theodore W.H, Fishbein D., Deitz M., Baldwin P. Complex partial seizures: cerebellar metabolism // Epilepsia. - 1987. - V.28. - P. 319-323.
     
621. 
     Theodore W.H, Rose D., Patronas N. et al. Cerebral glucose metabolism in the Lennox-Gastaut syndrome // Ann Neurol. - 1987. - V.21. - P. 14-21.
     
622. 
     Theodore W.H. Antiepileptic drugs and cerebral glucose metabolism // Epilepsia. - 1988.- V. 29, Suppl. 2. - P. 48-55.
     
623. 
     Theodore W.H. Epilepsy. In: Mazziotta JC, Gilman S, eds. Clinical brain imaging: principles and applications. Philadelphia: FA Davis, 1992. - V.136-165.
     
624. 
     Thomas P., Borg M., Suisse G, Chatel M. Opercular myoclonic-anarthric status epilepticus // Epilepsia. - 1995. - V. 36. - P. 281-289.
     
625. 
     Thomas P., Genton P., Wolf P., Gelisse P. Juvenile myoclinic epilepsy // Epileptic syndromes in Infancy, Childhood and Adolescence (3rd edn). J.Roger, M.Barbau, Ch.Dravet, P.Genton, C.A.Tassinari & PWfolf. 2002 John Libbey & Co Ltd, p. 335-355.
     
626. 
     Thomson P.J., Baxendale S.A., Duncan J.S., Sander J. W. Effects of Topiramte on cognitive function//J.neurol., neurosurg., psychiatry. - 2000. - V. 69. - P. 636-641.
     
627. 
     Touboul P.J., Arbeille Ph. Exploration ultrasonore neurovasculaire.- Paris: Masson, 1999.-118 p.
     
628. 
     Transcranial Doppler Sonography/Ed. R. Aaslid.- Wien, New York: Springer-Verlag, 1987.-176 p.
     
629. 
     Trimble M.R., Reynolds E.H. Antyconvulsant drugs and mental symptoms: a review // Psychol, med. - 1976. - V.6. - P. 169-178.
     
630. 
     Trinka E., Dilitz E., Unterberger I., Luef G et al. Non convulsive status epilepticus after replacement of valproate with lamotrigine // J Neurol. - 2002. - V.249. - P. 1417-1422.
     
631. 
     Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for serotonin in the mechanism of antidepressant action /P.L. Delgado, H.L. Miller, R.M. Salomon, J. Licinio //Biol. Psychiatry.- 1999. -Vol.46,-№9.-P.134-141.
     
632. 
     Tsai L. Y. Psychopharmacology in Autism // Psychosomatic Medicine. - 1999. - V. 61. - P. 651-665.
     
633. 
     Tuchman R.F, Volkmar F.R. Practice parameter: Screening and diagnosis of autism Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society // Neurology. - 2000. - V.55. - P. 468-479.
     
634. 
     Tuchman R.F. Acquired epileptiform aphasia // Semin Pediatr Neurol. - 1997. - V.4. - P. 93-101.
     
635. 
     Tuchman R.F., Rapin I. Regression in Pervasive Developmental Disorders: Seizures and Epileptiform Electroencephalogram Correlates // Pediatrics. - 1997. - Vol. 99. - P. 560-566.
     
636. 
     Tutuncuoglu S:, Serdaroglu G., Kadioglu B. Landau-Kleffner syndrome beginning with stut­tering: case report // J Child Neurol. - 2002. - V. 17. - P. 785-788.
     
637. 
     Ultrasonic Diagnosis of Cerebrovascular Disease/ Ed.M.P.Spencer.- Dordrecht: Martinus Nijhoff Publishers, 1997.- 306 p.
     
638. 
     Umbricht D., Degree/ G., Ban W.B. et al. Postictal and chronic psychoses in patients with temporal lobe epilepsy // Am J Psychiatry. - 1995. - V. 152. - P. 224-231.
     
639. 
     Vajda F. Valproate and neuroprotection // J. Clinical Neuroscience. - 2002. - V. 9. - P. 508-514.
     
640. 
     Vargha-Khadem F., Watkins K.E., Price C.J. et al. Neural basis of an inherited speech and language disorder// PNAS. - 1998. - V. 95. - P. 12695-12700.
     
641. 
     Veggiotti P., Cardinali S., Granoccio E. et al. Motor impairment on awakening in a patient with an EEG pattern of unilateral continuous spike and waves during slow sleep // Epileptic disorders. - 2005. - V. 7. - P. 131-136.
     
642. 
     Veiga H., DeslandesA., Cagy M. etal. Neurocortical electrical activity tomography in chron­ic schizophrenics // Arq Neuropsiquiatr. - 2003. - V. 61. - P. 712-717.
     
643. 
     Venter J.C., Fraser C. Neurotransmit. Receptors Mech Act.- New York, 1994.-P.271-288.
     
644. 
     Verrotti Alberto, Latini Giuseppe, Trotta Daniela et al. Population study of benign rolandic epilepsy: Is treatment needed? // Neurology. - 2002. - V. 59 - P. 476.
     
645. 
     Vetrugno R., Mascalchi M., Vella A. et al. Paroxysmal arousal in epilepsy associated with cin-gulate hyperperfusion // Neurology. - 2005. - V. 64 - P. 356-358.
     
646. 
     Volk Holger A., Loscher Wolfgang. Multidrug resistance in epilepsy: rats with drug-resistant seizures exhibit enhanced brain expression of P-glycoprotein compared with rats with drug-responsive seizures // Brain. - 2005. - V. 10. 1093/brain/awh437.
     
647. 
     Volkow N.D., Tancredi L. Neural substrates of violent behavior: a study with positron emis­sion tomography// Br J Psychiatry. - 1987. - V. 151 - P. 668-673.
     
648. 
     Wakai S., Yuko Y., Higashidate Y., Tachi N., Chiba S. Benign partial epilepsy with affective symptoms: hyperkinetic behavior during interictal periods // Epilepsia. - 1994. - V. 35 - P. 810-812.
     
649. 
     Waldie K.E., Mosley J.L. Developmental trends in right hemispheric participation in reading // Neuropsychologia. - 2000. - V. 38. - P. 462-474.
     
650. 
     Walter W.G., CooperR., Aldridge V.J., McCallum W.C., WinterA.L. Contingent negative vari­ation: an electric sign of sensorimotor association and expectancy iri the human brain // Nature. - 1964. - V. 203 - P. 380-384.
     
651. 
     Warburton D.M. Clinical Psychopharmacology of Ginkgo biloba extract /E.W. Funfeld (ed). Rokan* (Ginkgo biloba. Recent results in pharmacology and clinic. //Springer Verlag Berlin Heidelberg, New York. –1990. –P.327–345.
     
652. 
     Weglage J., Demsky A., Pietsch M., Kurlemann G. Neuropsychological, intellectual, and behavioral findings in patients with centrotemporal spikes with and without seizures // Dev Med Child. - Neurol. - 1997. - V. 39 - P. 646-651.
     
653. 
     Weiss S.R.B., Post R.M. Kindling: separate vs. shared mechanisms in affective disorders and epilepsy//Neuropsychobiology. - 1998. - V. 38 - P. 167-180.
     
654. 
     Welty Т.Е., Gidal B.E., Ficker D.M., Privitera M.D. Levetiracetam: a different approach to the pharmacotherapy of epilepsy //Ann. Pharmacother. - 2002. - V. 36 - P. 296 - 304.
     
655. 
     WieserH.G., Hailemariam S., Regard M., Landis T. Unilateral limbic epileptic status activi­ty: stereo EEG, behavioral, and cognitive data // Epilepsia. - 1985. - V. 26 - P. 19-29.
     
656. 
     Williams D. Neural factors related to habitual aggression: consideration of differences between those habitual aggressives and others who have committed crimes of violence // Brain. - 1969. - V.92 - P. 503-520.
     
657. 
     Williamson P.D., Spencer S.S. Clinical and EEG features of complex partial seizures of extratemporal origin // Epilepsia. - 1986. - V. 27. - P. S46-S63.
     
658. 
     Wolf P., Inoue Z., Roder- Wanner U.U., TsaiJ.J. Psychiatric complication of absence therapy and their relation to alteration of sleep // Epilepsia. - 1984. - V. 25 - P. 56-59.
     
659. 
     Wycis H.T., Lee A.J., Spiegel E.A. Simultaneous records of thalamic and cortical (scalp) potentials in schizophrenics and epileptics//Conf. neural. - 1949.- V. 9. - P. 264-271.
     
660. 
     Yalnizoglu D., Turanli G., Herguner O. et al. Report of eight cases with electrical status epilep­ticus during sleep: outcome with conventional versus new antiepileptic drugs // Epilepsia 2000, V.41 (suppl. 7), P. S182-183.
     
661. 
     Yani K, Linuma K, Matsuzawa T. et al. Cerebral glucose utilization in pediatric neurologi­cal disorders determined by positron emission tomography // Eur J Nucl Med. - 1987. - V.13-P. 292-296.
     
662. 
     Young A.H., Henry M.E., Moore C.M., Kaufman M.J./Brain kinetics of paroxetine and fluoxetine on the third day of placebo substitution //Amer. J. Psychiatry. – 2000.-Vol.157, N9.- P.1506-1508.
     
663. 
     Young A.H., Hughes J.H., Ashton C.H. Brain 5-ht function in bipolar affective disorder //Acta Neuropsychiatrica.-2000.-Vol.12, N3.-P.91-95.
     
664. 
     Yu H. Y, Nakasato N, Iwasaki M. et al. Neuromagnetic separation of secondarily bilateral syn­chronized spike foci: report of three cases // J Clin Neurosci. - 2004. - V. 11. - P. 644-648.
     
665. 
     Yuan P. -X., Huang L. -D., Jiang Y. -M. et al. The mood stabilizer valproic acid activates mito-gen-activated protein kinases and promotes neurite growth // J. Biol. Chem. - 2001. - V. 276. - P. 31674-31683.
     
666. 
     Yung A. W., Park Y.D., Cohen M.J., Garrison T.N. Cognitive and behavioral problems in chil­dren with centrotemporal spikes // Pediatr Neurol. - 2000. - V. 23. - P. 391-395.
     
667. 
     YungA.W., Park YD., Cohen M.J. etal. Use of Visual Evoked-Potential Studies and EEG Data to Classify Aggressive, Explosive Behavior of Youths // Psychiatr. Serv. - 2001. - V. 52-P. 81-86.
     
668. 
     ZaldD.H, Kim S.W. The anatomy and function of the orbito-frontal cortex, I: anatomy, neurocircuitry, and obsessive-compulsive disorder // J Neuropsychiatry Clin Neurosci. - 1996.-V. 8-P. 125-138.
     
669. 
     ZaldD.H., Kim S.W. Anatomy and function of the orbital frontal cortex, II: Function and relevance to obsessive-compulsive disorder//J. Neuropsychiatry. Clin. Neurosci. - 1996. - V. 8 - P. 249-261.
     
670. 
     Zaviazkina N. Investigation of cognitive functions during treatment with valproic acid // Epilepsia. - 2004. - V.45, Suppl. 3, P. 133-134.
     
671. 
     Zorzon Marino, Antonutti Lucia, Masci Giovanni et al. Transient Global Amnesia and Transient Ischemic Attack Natural History, Vascular Risk Factors, and Associated Conditions Stroke // 1995. - V.26 - P. 1536-1542.
     
672. 
     Zouari N, Choyakh F. Early, middle-latency and late auditory evoked potentials in a case of acquired epileptic aphasia (Landau-Klefmer syndrome) // Rev Laryngol Otol Rhinol (Bord). - 1997. - V 118. - P. 267-270.
     
673. 
     Zouhar A., Slapal R. Administration of high doses of B6 in age-related epileptic encephalopathies // Cesk Neurol Neurochir. - 1989. - V 52. - P. 28-31.
     
674. 
     Зенков Л.Р. (Zenkov L.R.) Brain-stem and long-latency auditory evoked potentials in acquired aphasia simulating surdomutism. In: Sixth ERA-Symposium. Pecs, Hungary, July 7-9. - 1988. - P. 83.
     
675. 
     Зенков Л.Р. (Zenkov L.R.) Cerebral Mechanisms of Epileptic and Non-epileptic Disorders and a Knowlege-based System for Their Differential Diagnosis //Epileptologia. - 1995. - Vol.4. - P. 348-358.
     
676. 
     Зенков Л.Р., Карлов В.А., Жидкова И.A. (Zenkov L.R., Karlov V.A., Zhidkova LA.) A knowl- ege-based system for differential diagnosis of epileptic and nonepileptic attacs. In: 2-nd Congr. Epileptol., Warszdawa, 1995. - P. 36.
     

Проф. Асадуллаев М.М. закончил с «отличием» лечебный факультет ТашГосМИ в 1970 г. и работал ординатором, после заведующим неврологическим отделением КБ Мз, с 1974 года–ассистентом кафедры нервных болезней ТашГосМИ. С 1980 года работал в Уз НИИ СГиПз старшим научным сотрудником, затем с 1981г. заведующим лабораторией.

С 1988 года–профессор кафедры нервных болезней ТашГосМИ, а с 1989 по 1993г. заведующий кафедрой нервных болезней ТашГосМИ – II, затем с 2005-2008г Ташкентской медицинской академии. С февраля 2008г.по настоящее время является профессором этой кафедры.

В 1973 г. проф. М.М. Асадуллаевым защищена кандидатская и в 1987 г. докторская диссертация.

Изданы 7 монографии, 3 учебника, 28 рацпредложений, более 390 научных статей и 25 методических рекомендаций. Подготовлены 6 доктора медицинских наук и 27 кандидатов медицинских наук.

В 1997 и 2002 гг. проф. Асадуллаев М.М. был удостоен звания лучшего профессора года ТашГосМИ-2, является победителем Республиканского конкурса фонда «Устоз» на звание «Лучшего научного руководителя Узбекистана» (1999г.), отличником здравоохранения Узбекистана (2002г.), действительном членом (академиком) Российский Академии Медико-Технических наук (2005).

Проф. Кариев Г.М. в 1988 году окончил Таш.Гос.МИ с «отличием», прошел клиническую ординатуру, затем аспирантуру на кафедре нейрохирургии Киевского ИУВ. В 1993 защищена кандидатская и 1999г. докторская диссертация.

С апреля 1993 года по 1997г. Кариев Г.М работал ассистентом на кафедре нейрохирургии, ВПХ и травматологии I-ТашГосМИ.

В 2001 -2005гг. работал заведующим кафедрой травматологии, нейрохирургии и ВПХ Ташкентской Медицинской академии. С декабря 2005 года перешел на основную работу руководителем отдела миниинвазивной нейрохирургии Республиканского научного центра нейрохирургии МЗ РУз.

С 2007 года по настоящее время является директором Республиканского научного центра нейрохирургии МзРУз.

Подготовлено 10 кандидатов наук и 1 доктор наук.

Опубликовано свыше 300 научных трудов, в том числе 2 монографии.

В период с 2004 по 2008 гг являлся вице-президентом азиатской ассоциации нейрохирургов, с 2008 г членом комитета по реконструктивной нейрохирургии и нейрореабилитации всемирной федерации нейрохирургов, с 2010 года главный нейрохирург МЗ Узбекистана

Асадуллаев У.М. окончил лечебный факультет II-ТашГосМИ в 1997г. в этом же году поступил в клиническую ординатуру на кафедру травматологии, ортопедии с нейрохирургией II-ТашГосМИ.

С 1999 года работает в Республиканском Научном Центре Нейрохирургии МзРУз младшим и с 2009г. старшим научным сотрудником. В 2004 году защитил кандидатскую диссертацию на тему – “Реакции микрососудов пиальной оболочки мозга и реологические свойства крови в остром периоде субарахноидального кровоизлияния”.

Опубликовано 77 научных статей, 4 методические рекомендации, имеет 2 изобретения и 1 рацпредложение.